miR	O
-	O
148	O
Regulates	O
Mitf	B-GP
in	O
Melanoma	B-DS
Cells	O

Conceived	O
and	O
designed	O
the	O
experiments	O
:	O
BSH	O
ES	O
.	O

Performed	O
the	O
experiments	O
:	O
BSH	O
KB	O
CP	O
.	O

Analyzed	O
the	O
data	O
:	O
BSH	O
.	O

Wrote	O
the	O
paper	O
:	O
BSH	O
ES	O
.	O

The	O
Microphthalmia	B-GP
associated	I-GP
transcription	I-GP
factor	I-GP
(	O
Mitf	B-GP
)	O
is	O
an	O
important	O
regulator	O
in	O
melanocyte	O
development	O
and	O
has	O
been	O
shown	O
to	O
be	O
involved	O
in	O
melanoma	B-DS
progression	O
.	O

The	O
current	O
model	O
for	O
the	O
role	O
of	O
Mitf	B-GP
in	O
melanoma	B-DS
assumes	O
that	O
the	O
total	O
activity	O
of	O
the	O
protein	O
is	O
tightly	O
regulated	O
in	O
order	O
to	O
secure	O
cell	O
proliferation	O
.	O

Previous	O
research	O
has	O
shown	O
that	O
regulation	O
of	O
Mitf	B-GP
is	O
complex	O
and	O
involves	O
regulation	O
of	O
expression	O
,	O
splicing	O
,	O
protein	O
stability	O
and	O
post	O
-	O
translational	O
modifications	O
.	O

Here	O
we	O
show	O
that	O
microRNAs	O
(	O
miRNAs	O
)	O
are	O
also	O
involved	O
in	O
regulating	O
Mitf	B-GP
in	O
melanoma	B-DS
cells	O
.	O

Sequence	O
analysis	O
revealed	O
conserved	O
binding	O
sites	O
for	O
several	O
miRNAs	O
in	O
the	O
Mitf	B-GP
3	O
′	O
UTR	O
sequence	O
.	O

Furthermore	O
,	O
miR	O
-	O
148	O
was	O
shown	O
to	O
affect	O
Mitf	B-GP
mRNA	O
expression	O
in	O
melanoma	B-DS
cells	O
through	O
a	O
conserved	O
binding	O
site	O
in	O
the	O
3	O
′	O
UTR	O
sequence	O
of	O
mouse	B-OG
and	O
human	B-OG
Mitf	B-GP
.	O

In	O
addition	O
we	O
confirm	O
the	O
previously	O
reported	O
effects	O
of	O
miR	O
-	O
137	O
on	O
Mitf	B-GP
.	O

Other	O
miRNAs	O
,	O
miR	O
-	O
27a	O
,	O
miR	O
-	O
32	O
and	O
miR	O
-	O
124	O
which	O
all	O
have	O
conserved	O
binding	O
sites	O
in	O
the	O
Mitf	B-GP
3	O
′	O
UTR	O
sequence	O
did	O
not	O
have	O
effects	O
on	O
Mitf	B-GP
.	O

Our	O
data	O
show	O
that	O
miR	O
-	O
148	O
and	O
miR	O
-	O
137	O
present	O
an	O
additional	O
level	O
of	O
regulating	O
Mitf	B-GP
expression	O
in	O
melanocytes	O
and	O
melanoma	B-DS
cells	O
.	O

Loss	O
of	O
this	O
regulation	O
,	O
either	O
by	O
mutations	O
or	O
by	O
shortening	O
of	O
the	O
3	O
′	O
UTR	O
sequence	O
,	O
is	O
therefore	O
a	O
likely	O
factor	O
in	O
melanoma	B-DS
formation	O
and	O
/	O
or	O
progression	O
.	O

Introduction	O

The	O
MITF	B-GP
(	O
Microphthalmia	B-GP
associated	I-GP
transcription	I-GP
factor	I-GP
)	O
protein	O
is	O
a	O
master	O
regulator	O
of	O
melanocyte	O
development	O
and	O
is	O
important	O
in	O
several	O
other	O
cell	O
types	O
including	O
the	O
retinal	O
pigment	O
epithelium	O
(	O
RPE	O
)	O
of	O
the	O
eye	O
,	O
osteoclasts	O
and	O
mast	O
cells	O
[	O
1	O
].	O

More	O
recently	O
,	O
MITF	B-GP
was	O
shown	O
to	O
play	O
a	O
role	O
in	O
melanocyte	O
stem	O
cells	O
in	O
the	O
hair	O
follicle	O
[	O
2	O
].	O

The	O
Mitf	B-GP
gene	O
encodes	O
a	O
bHLH	B-GP
-	I-GP
Zip	I-GP
transcription	I-GP
factor	I-GP
of	O
the	O
Myc	B-GP
family	O
[	O
3	O
],	O
[	O
4	O
]	O
which	O
regulates	O
melanocyte	O
differentiation	O
by	O
activating	O
other	O
known	O
melanocyte	O
determinants	O
,	O
including	O
Tyrosinase	B-GP
(	O
Tyr	B-GP
),	O
Tyrosinase	B-GP
-	I-GP
related	I-GP
protein	I-GP
-	I-GP
1	I-GP
(	O
Tyrp	B-GP
-	I-GP
1	I-GP
)	O
and	O
DCT	B-GP
/	O
Tyrp	B-GP
-	I-GP
2	I-GP
[	O
5	O
],	O
[	O
6	O
].	O

In	O
addition	O
to	O
regulating	O
differentiation	O
,	O
MITF	B-GP
is	O
required	O
for	O
melanocyte	O
cell	O
survival	O
[	O
7	O
],	O
[	O
8	O
],	O
proliferation	O
and	O
cell	O
cycle	O
progression	O
[	O
9	O
],	O
[	O
10	O
],	O
[	O
11	O
],	O
[	O
12	O
],	O
[	O
13	O
].	O

The	O
diverse	O
roles	O
that	O
MITF	B-GP
plays	O
in	O
the	O
development	O
of	O
different	O
cell	O
types	O
suggests	O
that	O
the	O
expression	O
and	O
function	O
of	O
Mitf	B-GP
must	O
be	O
highly	O
regulated	O
.	O

In	O
fact	O
,	O
Mitf	B-GP
is	O
regulated	O
at	O
multiple	O
levels	O
,	O
including	O
transcription	O
,	O
alternative	O
splicing	O
,	O
post	O
-	O
translational	O
modifications	O
and	O
protein	O
stability	O
.	O

The	O
Mitf	B-GP
gene	O
has	O
at	O
least	O
nine	O
different	O
promoters	O
,	O
each	O
with	O
a	O
unique	O
5	O
′	O
exon	O
which	O
is	O
alternatively	O
spliced	O
to	O
the	O
remaining	O
exons	O
2	O
through	O
9	O
resulting	O
in	O
several	O
different	O
Mitf	B-GP
isoforms	O
[	O
reviewed	O
in	O
1	O
].	O

At	O
the	O
protein	O
level	O
,	O
MITF	B-GP
is	O
modified	O
post	O
-	O
transcriptionally	O
and	O
has	O
been	O
shown	O
to	O
be	O
phosphorylated	O
at	O
multiple	O
sites	O
leading	O
to	O
either	O
increase	O
in	O
transcriptional	O
activation	O
or	O
decrease	O
in	O
protein	O
stability	O
[	O
14	O
],	O
[	O
15	O
],	O
[	O
16	O
],	O
[	O
17	O
].	O

In	O
addition	O
,	O
ubiquitination	O
marks	O
MITF	B-GP
for	O
degradaton	O
[	O
18	O
]	O
and	O
sumoylation	O
has	O
been	O
shown	O
to	O
affect	O
DNA	O
binding	O
specificity	O
[	O
19	O
],	O
[	O
20	O
].	O

In	O
addition	O
to	O
its	O
essential	O
role	O
in	O
melanocyte	O
development	O
,	O
expression	O
of	O
Mitf	B-GP
and	O
its	O
target	O
genes	O
is	O
seen	O
in	O
many	O
melanoma	B-DS
cells	O
[	O
21	O
],	O
[	O
22	O
].	O

Continued	O
expression	O
of	O
MITF	B-GP
has	O
been	O
shown	O
to	O
be	O
essential	O
for	O
melanoma	B-DS
cell	O
proliferation	O
and	O
survival	O
and	O
,	O
in	O
fact	O
,	O
MITF	B-GP
has	O
been	O
proposed	O
to	O
act	O
as	O
a	O
lineage	O
survival	O
oncogene	B-GP
in	O
melanoma	B-DS
[	O
23	O
].	O

Significantly	O
increased	O
levels	O
of	O
MITF	B-GP
,	O
however	O
,	O
reduce	O
melanoma	B-DS
cell	O
proliferation	O
and	O
tumorigenicity	O
[	O
24	O
],	O
[	O
25	O
].	O

Consistent	O
with	O
this	O
,	O
there	O
is	O
less	O
MITF	B-GP
expressed	O
in	O
melanoma	B-DS
cells	O
than	O
in	O
normal	O
melanocytes	O
[	O
25	O
].	O

Therefore	O
,	O
it	O
has	O
been	O
proposed	O
that	O
MITF	B-GP
levels	O
dictate	O
functional	O
outcome	O
such	O
that	O
high	O
levels	O
result	O
in	O
cell	O
cycle	O
arrest	O
and	O
differentiation	O
,	O
intermediate	O
levels	O
promote	O
proliferation	O
and	O
tumorigenesis	O
whereas	O
low	O
levels	O
lead	O
to	O
cell	O
cycle	O
arrest	O
and	O
apoptosis	O
.	O

According	O
to	O
this	O
model	O
,	O
it	O
is	O
extremely	O
important	O
to	O
regulate	O
MITF	B-GP
expression	O
in	O
melanoma	B-DS
cells	O
.	O

miRNAs	O
have	O
been	O
proven	O
to	O
be	O
involved	O
in	O
many	O
different	O
cell	O
processes	O
including	O
cell	O
-	O
cycle	O
regulation	O
,	O
differentiation	O
,	O
proliferation	O
and	O
apoptosis	O
[	O
reviewed	O
in	O
26	O
].	O

miRNAs	O
are	O
thought	O
to	O
regulate	O
about	O
30	O
%	O
of	O
coding	O
genes	O
in	O
the	O
human	B-OG
genome	O
and	O
to	O
date	O
677	O
miRNA	O
genes	O
have	O
been	O
discovered	O
in	O
the	O
human	B-OG
genome	O
and	O
491	O
in	O
the	O
mouse	B-OG
(	O
www	O
.	O
microRNA	O
.	O
org	O
)	O
[	O
27	O
].	O

Misexpression	O
of	O
miRNA	O
genes	O
has	O
been	O
seen	O
in	O
both	O
benign	O
and	O
malignant	B-DS
cancer	I-DS
and	O
miRNA	O
genes	O
can	O
act	O
as	O
either	O
tumor	B-DS
suppressors	O
or	O
oncogenes	B-GP
as	O
is	O
seen	O
for	O
the	O
role	O
of	O
coding	O
genes	O
in	O
cancer	B-DS
progression	O
.	O

Studies	O
have	O
shown	O
that	O
miRNA	O
expression	O
differs	O
between	O
melanoma	B-DS
cell	O
lines	O
[	O
28	O
]	O
and	O
that	O
miRNA	O
expression	O
profiles	O
can	O
be	O
used	O
to	O
classify	O
solid	B-DS
tumors	I-DS
in	O
terms	O
of	O
their	O
differentiation	O
stage	O
and	O
developmental	O
lineage	O
[	O
29	O
].	O

In	O
an	O
extensive	O
comparative	O
study	O
on	O
miRNA	O
expression	O
in	O
normal	O
melanocyte	O
and	O
melanoma	B-DS
cell	O
lines	O
derived	O
from	O
solid	B-DS
tumors	I-DS
and	O
melanoma	B-DS
metastases	O
,	O
various	O
miRNAs	O
were	O
found	O
to	O
be	O
differentially	O
regulated	O
in	O
melanoma	B-DS
cells	O
compared	O
to	O
normal	O
melanocytes	O
[	O
30	O
].	O

Many	O
had	O
not	O
been	O
linked	O
to	O
cancer	B-DS
formation	O
before	O
.	O

Other	O
miRNAs	O
had	O
been	O
shown	O
to	O
be	O
oncogenic	O
or	O
to	O
contain	O
tumor	B-DS
suppressive	O
potential	O
in	O
other	O
types	O
of	O
cancer	B-DS
[	O
30	O
].	O

A	O
few	O
miRNAs	O
have	O
already	O
been	O
linked	O
to	O
Mitf	B-GP
expression	O
.	O

Bemis	O
et	O
al	O
.	O
(	O
2008	O
)	O
showed	O
that	O
miR	O
-	O
137	O
downregulates	O
MITF	B-GP
in	O
melanoma	B-DS
cells	O
[	O
31	O
].	O

In	O
addition	O
,	O
it	O
has	O
been	O
shown	O
that	O
miR	O
-	O
182	O
targets	O
Mitf	B-GP
3	O
′	O
UTR	O
sequence	O
in	O
the	O
retina	O
[	O
32	O
],	O
and	O
recently	O
Segura	O
et	O
al	O
.	O
(	O
2009	O
)	O
showed	O
that	O
miR	O
-	O
182	O
promotes	O
migration	O
and	O
survival	O
of	O
melanoma	B-DS
cells	O
by	O
downregulating	O
Mitf	B-GP
expression	O
[	O
33	O
].	O

Here	O
we	O
study	O
miRNAs	O
with	O
conserved	O
binding	O
sites	O
in	O
the	O
Mitf	B-GP
3	O
′	O
UTR	O
sequence	O
and	O
characterize	O
their	O
effects	O
on	O
Mitf	B-GP
using	O
a	O
reporter	O
construct	O
.	O

Effects	O
on	O
the	O
endogenous	O
human	B-OG
MITF	B-GP
gene	O
were	O
also	O
determined	O
in	O
melanoma	B-DS
cells	O
.	O

Our	O
results	O
show	O
that	O
miRNAs	O
play	O
an	O
important	O
role	O
in	O
regulating	O
MITF	B-GP
mRNA	O
in	O
melanoma	B-DS
through	O
conserved	O
sites	O
in	O
the	O
3	O
′	O
UTR	O
.	O

Materials	O
and	O
Methods	O

PCR	O
amplification	O
of	O
the	O
3	O
′	O
UTR	O
sequence	O
of	O
Mitf	B-GP

A	O
reporter	O
gene	O
construct	O
was	O
generated	O
which	O
contains	O
the	O
mouse	B-OG
Mitf	B-GP
-	O
3	O
′	O
UTR	O
sequence	O
downstream	O
of	O
the	O
luciferase	B-GP
reporter	O
gene	O
.	O

The	O
construct	O
was	O
termed	O
mouseMitf	B-GP
-	O
3	O
′	O
UTR	O
-	O
luciferase	B-GP
.	O

To	O
do	O
this	O
,	O
the	O
3	O
′	O
UTR	O
sequence	O
of	O
the	O
mouse	B-OG
Mitf	B-GP
gene	O
(	O
which	O
is	O
contained	O
in	O
a	O
single	O
exon	O
)	O
was	O
amplified	O
from	O
BAC	O
clone	O
rpci	O
-	O
23	O
-	O
9a13t7	O
using	O
Pfu	B-GP
polymerase	I-GP
and	O
the	O
primers	O
3UTRSacI	O
-	O
Forw	O
:	O
5	O
′-	O
gag	O
ctc	O
cga	O
gcc	O
tgc	O
ctt	O
gct	O
ctg	O
-	O
3	O
′	O
and	O
3UTRNheI	O
-	O
Rev	O
:	O
5	O
′-	O
gct	O
agc	O
atg	O
tga	O
aaa	O
acc	O
aaa	O
tgc	O
ttt	O
aat	O
ga	O
-	O
3	O
′.	O

The	O
primers	O
included	O
new	O
restriction	O
sites	O
,	O
SacI	B-GP
at	O
the	O
5	O
′	O
end	O
and	O
NheI	B-GP
at	O
the	O
3	O
′	O
end	O
(	O
underlined	O
bases	O
).	O

The	O
restriction	O
sites	O
were	O
used	O
for	O
cloning	O
into	O
the	O
Pis0	O
vector	O
,	O
a	O
Firefly	B-OG
luciferase	B-GP
vector	O
,	O
modified	O
from	O
the	O
PGL3	O
Control	O
Vector	O
from	O
Promega	O
by	O
adding	O
restriction	O
sites	O
to	O
the	O
3	O
′	O
end	O
.	O

The	O
Pis0	O
vector	O
was	O
purchased	O
from	O
Addgene	O
Inc	O
.	O

Cambridge	O
,	O
MA	O
,	O
USA	O
(	O
Addgene	O
plasmid	O
12178	O
)	O
[	O
34	O
].	O

Site	O
directed	O
mutagenesis	O
was	O
used	O
to	O
alter	O
the	O
miRNA	O
target	O
sites	O
using	O
the	O
mouseMitf	B-GP
-	O
3	O
′	O
UTR	O
-	O
luciferase	B-GP
clone	O
as	O
a	O
template	O
.	O

MicroRNA	O
molecules	O

MicroRNAs	O
used	O
in	O
this	O
study	O
were	O
purchased	O
from	O
Ambion	O
,	O
Inc	O
.	O
and	O
are	O
the	O
following	O
:	O
hsa	O
-	O
miR	O
-	O
27a	O
(	O
Product	O
ID	O
:	O
PM10939	O
),	O
hsa	O
-	O
miR	O
-	O
32	O
(	O
Product	O
ID	O
:	O
PM10124	O
),	O
hsa	O
-	O
miR	O
-	O
101	O
(	O
Product	O
ID	O
:	O
PM10537	O
),	O
mmu	O
-	O
miR	O
-	O
124a	O
(	O
Product	O
ID	O
:	O
PM10691	O
),	O
mmu	O
-	O
miR	O
-	O
137	O
(	O
Product	O
ID	O
:	O
PM10513	O
),	O
hsa	O
-	O
miR	O
-	O
148a	O
(	O
Product	O
ID	O
:	O
PM10263	O
),	O
hsa	O
-	O
miR	O
-	O
182	O
.	O

(	O
Product	O
ID	O
:	O
PM11090	O
),	O
Pre	O
-	O
miR	O
-	O
neg	O
#	O
2	O
(	O
Cat	O
.	O
no	O
.	O
AM17111	O
),	O
Cy3	O
-	O
labeled	O
Pre	O
-	O
miR	O
Negative	O
Control	O
#	O
1	O
(	O
Cat	O
.	O
no	O
.	O
AM17120	O
).	O

MicroRNA	O
inhibitors	O

anti	O
-	O
microRNA	O
where	O
purchased	O
from	O
Ambion	O
and	O
are	O
the	O
following	O
:	O
anti	O
-	O
miR	O
-	O
137	O
(	O
Product	O
ID	O
:	O
AM10513	O
)	O
and	O
anti	O
-	O
miR	O
-	O
148	O
(	O
Product	O
ID	O
:	O
AM10263	O
).	O

Cell	O
culture	O
conditions	O

Human	B-OG
embryonic	O
kidney	O
cells	O
(	O
HEK293	O
)	O
were	O
cultured	O
in	O
DMEM	O
medium	O
with	O
10	O
%	O
FBS	O
,	O
penicillin	O
-	O
streptomycin	O
(	O
50	O
U	O
/	O
ml	O
)	O
and	O
2	O
mM	O
glutamine	O
.	O

501mel	O
melanoma	B-DS
cells	O
were	O
cultured	O
in	O
RPMI	O
medium	O
with	O
10	O
%	O
FBS	O
and	O
penicillin	O
-	O
streptomycin	O
(	O
50	O
U	O
/	O
ml	O
).	O

MeWo	O
melanoma	B-DS
cells	O
were	O
cultured	O
in	O
DMEM	O
medium	O
with	O
7	O
%	O
FBS	O
,	O
penicillin	O
-	O
streptomycin	O
(	O
50	O
U	O
/	O
ml	O
)	O
and	O
2	O
mM	O
glutamine	O
.	O

Cells	O
were	O
grown	O
at	O
37	O
°	O
C	O
with	O
5	O
%	O
CO2	O
.	O

Co	O
-	O
transfection	O

DNA	O
and	O
miRNAs	O
were	O
co	O
-	O
transfected	O
into	O
HEK293	O
and	O
501mel	O
cells	O
with	O
Lipofectamine	O
2000	O
from	O
Invitrogen	O
(	O
Cat	O
no	O
.	O
11668	O
-	O
019	O
)	O
in	O
Optimem	O
I	O
+	O
Glutamax	O
-	O
I	O
Reduced	O
Serum	O
Medium	O
from	O
Invitrogen	O
(	O
Cat	O
.	O
no	O
.	O
51985	O
),	O
according	O
to	O
the	O
manufacturers	O
protocol	O
.	O

Cells	O
were	O
grown	O
in	O
96	O
well	O
plates	O
.	O

In	O
each	O
well	O
10	O
ng	O
vector	O
DNA	O
,	O
0	O
.	O
2	O
ng	O
of	O
Renilla	B-OG
luciferase	B-GP
DNA	O
and	O
an	O
miRNA	O
at	O
either	O
0	O
.	O
1	O
pmol	O
,	O
0	O
.	O
5	O
pmol	O
or	O
1	O
pmol	O
concentration	O
were	O
co	O
-	O
transfected	O
.	O

A	O
negative	O
control	O
was	O
included	O
in	O
all	O
co	O
-	O
transfections	O
.	O

For	O
co	O
-	O
tranfection	O
with	O
the	O
mutated	O
3	O
′	O
UTR	O
clones	O
we	O
analysed	O
the	O
highest	O
concentration	O
in	O
each	O
case	O
,	O
or	O
1	O
pmol	O
miRNA	O
.	O

miRNA	O
inhibitors	O
were	O
transfected	O
at	O
concentration	O
of	O
1	O
pmol	O
miRNA	O
.	O

Transfected	O
cells	O
were	O
incubated	O
for	O
48	O
hrs	O
.	O
at	O
37	O
°	O
C	O
with	O
5	O
%	O
CO2	O
before	O
luciferase	B-GP
expression	O
was	O
measured	O
.	O

Experiments	O
were	O
repeated	O
three	O
times	O
in	O
6	O
replicates	O
,	O
except	O
experiments	O
when	O
two	O
different	O
miRNAs	O
were	O
co	O
-	O
transfected	O
simultaneously	O
which	O
was	O
done	O
only	O
once	O
in	O
six	O
replicates	O
.	O

Luciferase	B-GP
measurements	O

The	O
Dual	O
Luciferase	B-GP
Reporter	O
Assay	O
System	O
from	O
Promega	O
was	O
used	O
to	O
measure	O
luciferase	B-GP
expression	O
on	O
a	O
Wallac	O
Victor	O
2	O
1420	O
Multilabel	O
counter	O
.	O

Mutagenesis	O

Locations	O
of	O
miRNA	O
binding	O
sites	O
were	O
determined	O
using	O
the	O
mRNA	O
sequence	O
of	O
mouse	B-OG
Mitf	B-GP
3	O
′	O
UTR	O
and	O
are	O
numbered	O
starting	O
at	O
the	O
first	O
nucleotide	O
after	O
the	O
stop	O
codon	O
.	O

Quikchange	O
Lightning	O
Site	O
-	O
directed	O
Mutagenesis	O
Kit	O
from	O
Stratagene	O
(	O
Cat	O
.	O
no	O
.#	O
10518	O
)	O
was	O
used	O
to	O
mutate	O
the	O
miRNA	O
binding	O
sites	O
in	O
the	O
mouse	B-OG
Mitf	B-GP
3	O
′	O
UTR	O
sequence	O
.	O

Primers	O
were	O
designed	O
using	O
the	O
Primerdesign	O
program	O
from	O
Promega	O
(	O
Table	O
1	O
).	O

In	O
order	O
to	O
avoid	O
the	O
possibility	O
that	O
the	O
mutated	O
sequence	O
itself	O
forms	O
a	O
microRNA	O
target	O
,	O
the	O
corresponding	O
“	O
new	O
”	O
seed	O
region	O
was	O
used	O
to	O
search	O
for	O
predicted	O
targets	O
of	O
novel	O
small	O
RNAs	O
in	O
TargetscanCustom	O
4	O
.	O
2	O
.	O

(	O
http	O
://	O
www	O
.	O
targetscan	O
.	O
org	O
/	O
vert_42	O
/	O
seedmatch	O
.	O
html	O
).	O

Primers	O
used	O
for	O
mutagenesis	O
.	O

Primer	O
name	O

Sequence	O

miR	O
-	O
124	O
(	O
548	O
-	O
554	O
)	O
F	O

5	O
′-	O
ggcaatttcctggtactcgggcccagacacagtgccc	O
-	O
3	O
′	O

miR	O
-	O
124	O
(	O
548	O
-	O
554	O
)	O
R	O

5	O
′-	O
gggcactgtgtctgggcccgagtaccaggaaattgcc	O
-	O
3	O
′	O

miR	O
-	O
124	O
(	O
1639	O
-	O
1646	O
)	O
F	O

5	O
′-	O
gcataccctttcagaatgaagccgggccaaaatctcagcagtctc	O
-	O
3	O
′	O

miR	O
-	O
124	O
(	O
1639	O
-	O
1646	O
)	O
R	O

5	O
′-	O
gagactgctgagattttggcccgg	O
cttcattctgaaagggtatgc	O
-	O
3	O
′	O

miR	O
-	O
137	O
(	O
2495	O
-	O
2501	O
)	O
F	O

5	O
′-	O
gctgggagaggcaggccccgggcttagaggtgacaacataggg	O
-	O
3	O
′	O

miR	O
-	O
137	O
(	O
2495	O
-	O
2501	O
)	O
R	O

5	O
′-	O
ccctatgttgtcacctctaagcccggggcctgcctctcccagc	O
-	O
3	O
′	O

miR	O
-	O
137	O
(	O
2782	O
-	O
2788	O
)	O
F	O

5	O
′-	O
gccaaaaactgtgccccgggcctggtcatacccagagcatgatgcag	O
-	O
3	O
′	O

miR	O
-	O
137	O
(	O
2782	O
-	O
2788	O
)	O
R	O

5	O
′-	O
ctgcatcatgctctgggtatgaccaggcccggggcacagtttttggc	O
-	O
3	O
′	O

miR	O
-	O
137	O
(	O
2842	O
-	O
2848	O
)	O
F	O

5	O
′-	O
ggttgtttgtaaacaataaccgggccagaataaacaaaatgcacagg	O
-	O
3	O
′	O

miR	O
-	O
137	O
(	O
2842	O
-	O
2848	O
)	O
R	O

5	O
′-	O
cctgtgcattttgtttattctggcccggttattgtttacaaacaacc	O
-	O
3	O
′	O

miR	O
-	O
137	O
(	O
3061	O
-	O
3067	O
)	O
F	O

5	O
′-	O
gccccccgctgttgggtacccgggccctttctgtatggtccgc	O
-	O
3	O
′	O

miR	O
-	O
137	O
(	O
3061	O
-	O
3067	O
)	O
R	O

5	O
′-	O
gcggaccatacagaaagggcccgggtacccaacagcggggggc	O
-	O
3	O
′	O

miR	O
-	O
148	O
/	O
152	O
(	O
1674	O
-	O
1680	O
)	O
F	O

5	O
′-	O
cagcagtctcttttggaccagcagcccctgaactgtaactaggag	O
-	O
3	O
′	O

miR	O
-	O
148	O
/	O
152	O
(	O
1674	O
-	O
1680	O
)	O
R	O

5	O
′-	O
ctcctagttacagttcaggggctgctggtccaaaagagactgctg	O
-	O
3	O
′	O

miR	O
-	O
148	O
/	O
152	O
(	O
2931	O
-	O
2937	O
)	O
F	O

5	O
′-	O
gttaatatttctgaaaaaaaaccgggccgggagaagttgatgttg	O
-	O
3	O
′	O

miR	O
-	O
148	O
/	O
152	O
(	O
2931	O
-	O
2937	O
)	O
R	O

5	O
′-	O
caacatcaacttctcccggcccggttttttttcagaaatattaac	O
-	O
3	O
′	O

Mutated	O
bases	O
are	O
bold	O
and	O
underlined	O
.	O

Transfection	O
of	O
miRNAs	O
into	O
MeWo	O
cells	O

Cells	O
were	O
plated	O
at	O
1	O
.	O
4	O
−	O
2	O
×	O
105	O
density	O
on	O
6	O
well	O
plates	O
.	O

The	O
following	O
day	O
,	O
20	O
pmol	O
miRNA	O
or	O
20	O
pmol	O
miRNA	O
together	O
with	O
20	O
pmol	O
of	O
the	O
anti	O
-	O
miRNA	O
were	O
transfected	O
in	O
triplicate	O
with	O
Lipofectamin	O
2000	O
and	O
total	O
RNA	O
isolated	O
for	O
qRT	O
-	O
PCR	O
analysis	O
48	O
hrs	O
.	O
post	O
transfection	O
.	O

Subsequently	O
,	O
proteins	O
were	O
extracted	O
and	O
analyzed	O
.	O

RNA	O
extraction	O
and	O
cDNA	O
synthesis	O

Total	O
RNA	O
was	O
extracted	O
from	O
MeWo	O
cells	O
using	O
TRIzol	O
Reagent	O
(	O
Invitrogen	O
),	O
according	O
to	O
the	O
manufacturers	O
protocol	O
[	O
35	O
].	O

RNA	O
quantity	O
was	O
measured	O
using	O
Nanodrop	O
Spectrophotometer	O
ND	O
-	O
1000	O
and	O
RNA	O
integrity	O
was	O
determined	O
using	O
Agilent	O
2100	O
Bioanalyzer	O
.	O

RNA	O
Integrity	O
number	O
was	O
above	O
7	O
.	O
6	O
in	O
all	O
cases	O
.	O

RNA	O
was	O
treated	O
with	O
DNAseI	B-GP
and	O
purified	O
with	O
the	O
RNEasy	O
Minelute	O
kit	O
from	O
Qiagen	O
.	O

Purified	O
RNA	O
(	O
1	O
µg	O
in	O
10	O
µl	O
reaction	O
)	O
was	O
used	O
for	O
cDNA	O
synthesis	O
with	O
Superscript	O
III	O
RT	O
(	O
200	O
U	O
/	O
µl	O
),	O
and	O
anchored	O
Oligo	O
(	O
dT	O
)	O
20	O
primer	O
according	O
to	O
the	O
manufacturers	O
protocol	O
.	O

The	O
RNA	O
samples	O
were	O
tested	O
for	O
absence	O
of	O
inhibitors	O
using	O
the	O
SPUD	O
assay	O
-	O
no	O
inhibitors	O
were	O
detected	O
[	O
36	O
].	O

Quantitative	O
reverse	O
transcription	O
PCR	O

Human	B-OG
MITF	B-GP
mRNA	O
was	O
measured	O
in	O
total	O
RNA	O
samples	O
extracted	O
from	O
MeWo	O
cells	O
,	O
using	O
the	O
human	B-OG
MITF	B-GP
FAM	O
-	O
labelled	O
TaqMan	O
Gene	O
Expression	O
Assay	O
(	O
hs01115560	O
)	O
(	O
Applied	O
Biosystems	O
).	O

Samples	O
were	O
measured	O
in	O
triplicate	O
.	O

Two	O
controls	O
were	O
included	O
,	O
one	O
without	O
RT	O
and	O
the	O
other	O
without	O
template	O
.	O

Standard	O
conditions	O
for	O
TaqMan	O
reagents	O
were	O
used	O
.	O

The	O
results	O
were	O
normalized	O
to	O
total	O
RNA	O
(	O
Log250	O
).	O
β	B-GP
-	I-GP
actin	I-GP
was	O
used	O
as	O
a	O
control	O
for	O
the	O
miRNA	O
inhibitor	O
experiment	O
.	O

qRT	O
-	O
PCR	O
results	O
were	O
analysed	O
using	O
the	O
GenEx	O
Std	O
.	O

4	O
.	O
4	O
.	O
2	O
.	O
software	O
from	O
MultiD	O
analyses	O
AB	O
(	O
Sweden	O
).	O

Western	O
blot	O

Proteins	O
were	O
isolated	O
from	O
the	O
phenol	O
-	O
ethanol	O
supernatant	O
after	O
RNA	O
and	O
DNA	O
had	O
been	O
isolated	O
using	O
the	O
Trizol	O
reagent	O
(	O
Invitrogen	O
),	O
according	O
to	O
the	O
manufacturers	O
protocol	O
[	O
35	O
].	O

The	O
proteins	O
were	O
separated	O
on	O
a	O
10	O
%	O
SDS	O
-	O
PAGE	O
polyacrylamide	O
gel	O
.	O

The	O
proteins	O
were	O
electroblotted	O
onto	O
a	O
PVDF	O
transfer	O
membrane	O
(	O
Thermo	O
Scientific	O
).	O

The	O
membrane	O
was	O
immunoblotted	O
overnight	O
at	O
4	O
°	O
C	O
with	O
primary	O
antibody	O
,	O
(	O
C5	O
mouse	B-OG
-	O
anti	O
-	O
Mitf	B-GP
monoclonal	O
antibody	O
),	O
in	O
Tris	O
-	O
buffered	O
saline	O
with	O
5	O
%	O
milk	O
.	O

The	O
C5	O
mouse	B-OG
-	O
anti	O
-	O
Mitf	B-GP
monoclonal	O
antibody	O
is	O
raised	O
against	O
the	O
N	O
-	O
terminus	O
of	O
MITF	B-GP
.	O

This	O
antibody	O
detects	O
all	O
isoforms	O
of	O
MITF	B-GP
and	O
does	O
not	O
differentiate	O
between	O
them	O
.	O

A	O
horse	B-OG
-	I-OG
radish	I-OG
peroxidase	B-GP
labelled	O
anti	O
-	O
mouse	B-OG
secondary	O
antibody	O
(	O
Jackson	O
)	O
was	O
incubated	O
with	O
the	O
membrane	O
for	O
1	O
hr	O
.	O
after	O
washing	O
with	O
TBST	O
.	O

Signals	O
were	O
detected	O
with	O
ECL	O
reagent	O
from	O
Thermo	O
Scientific	O
.	O

Endogenous	O
miRNA	O
expression	O

Total	O
RNA	O
was	O
isolated	O
from	O
MeWo	O
,	O
501mel	O
and	O
HEK293	O
cells	O
as	O
before	O
and	O
samples	O
in	O
triplicate	O
were	O
sent	O
to	O
Exiqon	O
for	O
analysis	O
using	O
the	O
miRCURY	O
LNA	O
microRNA	O
PCR	O
system	O
.	O

PCR	O
assays	O
for	O
hsa	O
-	O
miR	O
-	O
137	O
(	O
MIMAT0000429	O
),	O
hsa	O
-	O
miR	O
-	O
124	O
(	O
MIMAT0000422	O
),	O
hsa	O
-	O
miR	O
-	O
506	O
(	O
MIMAT0002878	O
),	O
hsa	O
-	O
miR	O
-	O
148a	O
(	O
MIMAT0000243	O
),	O
hsa	O
-	O
miR	O
-	O
148b	O
(	O
MIMAT0000759	O
)	O
and	O
hsa	O
-	O
miR	O
-	O
152	O
(	O
MIMAT0000438	O
)	O
were	O
used	O
to	O
measure	O
endogenous	O
miRNA	O
expression	O
.	O

Statistical	O
analysis	O

T	O
-	O
test	O
analysis	O
(	O
for	O
independent	O
groups	O
)	O
was	O
performed	O
on	O
results	O
from	O
the	O
luciferase	B-GP
assays	O
,	O
qRT	O
-	O
PCR	O
results	O
from	O
transfection	O
in	O
MeWo	O
cells	O
and	O
endogenous	O
miRNA	O
expression	O
analysis	O
.	O

Results	O

The	O
Mitf	B-GP
3	O
′	O
UTR	O
sequence	O
and	O
potential	O
microRNA	O
binding	O
sites	O

The	O
mouse	B-OG
and	O
human	B-OG
Mitf	B-GP
3	O
′	O
UTR	O
sequences	O
are	O
unusually	O
long	O
or	O
over	O
3	O
kb	O
in	O
length	O
.	O

This	O
is	O
considerably	O
larger	O
than	O
the	O
average	O
mouse	B-OG
and	O
human	B-OG
3	O
′	O
UTR	O
sequences	O
which	O
are	O
559	O
and	O
826	O
nucleotides	O
,	O
respectively	O
[	O
37	O
].	O

The	O
overall	O
conservation	O
of	O
the	O
Mitf	B-GP
3	O
′	O
UTR	O
sequence	O
in	O
11	O
vertebrate	O
species	O
is	O
36	O
%	O
[	O
38	O
]	O
which	O
is	O
very	O
high	O
for	O
a	O
non	O
-	O
coding	O
region	O
.	O

This	O
suggests	O
a	O
functional	O
relevance	O
of	O
the	O
3	O
′	O
UTR	O
sequence	O
of	O
Mitf	B-GP
.	O

Using	O
the	O
TargetScan	O
program	O
(	O
www	O
.	O
targetscan	O
.	O
org	O
),	O
we	O
identified	O
several	O
miRNA	O
binding	O
sites	O
located	O
in	O
the	O
most	O
conserved	O
areas	O
of	O
the	O
3	O
′	O
UTR	O
region	O
.	O

We	O
tested	O
the	O
effects	O
of	O
microRNAs	O
which	O
have	O
conserved	O
binding	O
sites	O
in	O
the	O
3	O
′	O
UTR	O
region	O
of	O
Mitf	B-GP
,	O
including	O
miR	O
-	O
27a	O
(	O
located	O
at	O
229	O
–	O
235	O
in	O
the	O
mouse	B-OG
Mitf	B-GP
3	O
′	O
UTR	O
sequence	O
),	O
miR	O
-	O
25	O
/	O
32	O
/	O
92	O
/	O
363	O
/	O
367	O
(	O
1491	O
–	O
1497	O
),	O
miR	O
-	O
101	O
/	O
144	O
(	O
3023	O
–	O
3029	O
),	O
miR	O
-	O
124	O
/	O
506	O
(	O
1639	O
–	O
1646	O
)	O
and	O
miR	O
-	O
148	O
/	O
152	O
(	O
1674	O
–	O
1680	O
and	O
2931	O
–	O
2937	O
)	O
(	O
Fig	O
.	O
1A	O
and	O
1B	O
).	O

miR	O
-	O
124	O
/	O
506	O
also	O
has	O
a	O
less	O
conserved	O
binding	O
site	O
at	O
548	O
–	O
554	O
,	O
and	O
was	O
therefore	O
also	O
tested	O
in	O
our	O
study	O
.	O

In	O
addition	O
,	O
the	O
potential	O
binding	O
sites	O
for	O
miR	O
-	O
137	O
were	O
tested	O
as	O
the	O
mouse	B-OG
and	O
human	B-OG
Mitf	B-GP
3	O
′	O
UTR	O
sequences	O
both	O
contain	O
two	O
well	O
conserved	O
miR	O
-	O
137	O
binding	O
sites	O
located	O
in	O
close	O
proximity	O
to	O
each	O
other	O
,	O
137C	O
(	O
2842	O
–	O
2848	O
)	O
and	O
137D	O
(	O
3061	O
–	O
3067	O
).	O

Two	O
additional	O
less	O
conserved	O
miR	O
-	O
137	O
binding	O
sites	O
were	O
found	O
,	O
one	O
only	O
in	O
the	O
mouse	B-OG
3	O
′	O
UTR	O
,	O
namely	O
137A	O
(	O
2495	O
–	O
2501	O
)	O
and	O
one	O
conserved	O
in	O
the	O
mouse	B-OG
and	O
rat	B-OG
3	O
′	O
UTR	O
sequences	O
,	O
137B	O
(	O
2782	O
–	O
2788	O
).	O

It	O
has	O
been	O
shown	O
that	O
single	O
miRNAs	O
with	O
multiple	O
binding	O
sites	O
in	O
a	O
3	O
′	O
UTR	O
sequence	O
have	O
increased	O
effects	O
as	O
compared	O
to	O
miRNAs	O
with	O
only	O
a	O
single	O
binding	O
site	O
[	O
39	O
],	O
[	O
40	O
].	O

This	O
is	O
also	O
true	O
when	O
the	O
binding	O
sites	O
are	O
located	O
in	O
close	O
proximity	O
to	O
each	O
other	O
[	O
41	O
].	O

In	O
some	O
cases	O
,	O
several	O
different	O
miRNA	O
molecules	O
can	O
potentially	O
bind	O
to	O
the	O
same	O
binding	O
site	O
.	O

In	O
these	O
cases	O
only	O
one	O
representative	O
miRNA	O
molecule	O
was	O
chosen	O
to	O
test	O
the	O
functionality	O
of	O
that	O
specific	O
binding	O
site	O
.	O

If	O
the	O
representative	O
miRNA	O
was	O
able	O
to	O
downregulate	O
via	O
the	O
binding	O
site	O
,	O
it	O
indicates	O
that	O
the	O
other	O
potential	O
miRNAs	O
may	O
also	O
be	O
able	O
to	O
regulate	O
Mitf	B-GP
expression	O
.	O

miR	O
-	O
182	O
has	O
been	O
shown	O
previously	O
to	O
target	O
the	O
3	O
′	O
UTR	O
of	O
Mitf	B-GP
and	O
was	O
used	O
as	O
a	O
positive	O
control	O
[	O
32	O
].	O

Schematic	O
presentation	O
of	O
the	O
mouse	B-OG
Mitf	B-GP
-	O
3	O
′	O
UTR	O
sequence	O
.	O

A	O
.	O

The	O
line	O
indicates	O
the	O
3	O
′	O
UTR	O
region	O
of	O
the	O
mouse	B-OG
Mitf	B-GP
gene	O
,	O
including	O
the	O
coding	O
region	O
of	O
exon	O
9	O
.	O

Potential	O
binding	O
sites	O
for	O
miR	O
-	O
27	O
,	O
miR	O
-	O
124	O
/	O
506	O
,	O
miR	O
-	O
25	O
/	O
32	O
/	O
92	O
/	O
363	O
/	O
367	O
,	O
miR	O
-	O
148	O
/	O
152	O
,	O
miR	O
-	O
137	O
and	O
miR	O
-	O
101	O
/	O
144	O
in	O
the	O
mMitf	B-GP
3	O
′	O
UTR	O
sequence	O
are	O
indicated	O
below	O
the	O
line	O
and	O
potential	O
PAS	O
sites	O
above	O
.	O

Positions	O
are	O
based	O
on	O
the	O
mouse	B-OG
Mitf	B-GP
3	O
′	O
UTR	O
sequence	O
and	O
are	O
numbered	O
starting	O
at	O
the	O
first	O
nucleotide	O
after	O
the	O
stop	O
codon	O
.	O

Black	O
bars	O
:	O
miR	O
-	O
124	O
/	O
506	O
binding	O
sites	O
,	O
dark	O
grey	O
bars	O
:	O
miR	O
-	O
137	O
binding	O
sites	O
,	O
light	O
grey	O
bars	O
:	O
miR	O
-	O
148	O
/	O
152	O
binding	O
sites	O
,	O
white	O
bars	O
:	O
miR	O
-	O
27	O
,	O
miR	O
-	O
25	O
/	O
32	O
/	O
92	O
/	O
363	O
/	O
367	O
and	O
miR	O
-	O
101	O
/	O
144	O
.	O

B	O
.	O

The	O
conservation	O
of	O
potential	O
miRNA	O
binding	O
sites	O
in	O
the	O
Mitf	B-GP
3	O
′	O
UTR	O
sequence	O
.	O

Dots	O
represent	O
a	O
conserved	O
base	O
,	O
short	O
lines	O
represent	O
absence	O
of	O
a	O
sequence	O
at	O
this	O
location	O
.	O

C	O
.	O

Mutations	O
made	O
in	O
the	O
Mitf	B-GP
3	O
′	O
UTR	O
sequence	O
.	O

The	O
wild	O
type	O
mouse	B-OG
Mitf	B-GP
mRNA	O
sequence	O
is	O
shown	O
with	O
potential	O
binding	O
sites	O
indicated	O
in	O
red	O
.	O

The	O
mature	O
miRNA	O
sequence	O
and	O
potential	O
binding	O
between	O
the	O
miRNA	O
seed	O
region	O
to	O
the	O
3	O
′	O
UTR	O
sequence	O
are	O
shown	O
and	O
mutated	O
bases	O
are	O
indicated	O
above	O
the	O
mRNA	O
sequence	O
.	O

miR	O
-	O
148	O
/	O
152	O
affects	O
mMitf	B-GP
RNA	O
in	O
melanoma	B-DS
cells	O

To	O
test	O
the	O
functionality	O
of	O
the	O
miRNA	O
binding	O
sites	O
,	O
the	O
mouse	B-OG
Mitf	B-GP
3	O
′	O
UTR	O
sequence	O
was	O
cloned	O
downstream	O
of	O
a	O
luciferase	B-GP
reporter	O
gene	O
.	O

This	O
vector	O
was	O
then	O
co	O
-	O
transfected	O
into	O
cells	O
together	O
with	O
single	O
miRNA	O
molecules	O
and	O
effects	O
of	O
the	O
specific	O
miRNAs	O
on	O
expression	O
determined	O
by	O
measuring	O
luciferase	B-GP
activity	O
.	O

In	O
501mel	O
cells	O
,	O
miR	O
-	O
148	O
had	O
significant	O
effects	O
on	O
expression	O
of	O
the	O
mouseMitf	B-GP
-	O
3	O
′	O
UTR	O
-	O
luciferase	B-GP
reporter	O
(	O
Fig	O
.	O
2A	O
).	O

Co	O
-	O
transfection	O
with	O
miR	O
-	O
101	O
resulted	O
in	O
some	O
downregulation	O
of	O
the	O
reporter	O
whereas	O
other	O
miRNAs	O
tested	O
did	O
not	O
show	O
statistically	O
significant	O
effects	O
compared	O
to	O
the	O
mouseMitf	B-GP
-	O
3	O
′	O
UTR	O
-	O
luciferase	B-GP
vector	O
alone	O
.	O

When	O
determining	O
how	O
effective	O
each	O
miRNA	O
was	O
in	O
our	O
assay	O
,	O
the	O
expression	O
from	O
the	O
vector	O
when	O
co	O
-	O
transfected	O
with	O
the	O
miRNA	O
was	O
compared	O
to	O
the	O
expression	O
from	O
the	O
vector	O
alone	O
.	O

Effects	O
of	O
microRNAs	O
on	O
the	O
Mitf	B-GP
-	O
3	O
′	O
UTR	O
-	O
luciferase	B-GP
reporter	O
.	O

A	O
.	O

Effects	O
of	O
miRNAs	O
on	O
the	O
mouseMitf	B-GP
-	O
3	O
′	O
UTR	O
-	O
luciferase	B-GP
reporter	O
in	O
501melanoma	O
cells	O
.	O

Three	O
concentrations	O
of	O
miRNAs	O
were	O
tested	O
:	O
0	O
.	O
1	O
pmol	O
,	O
0	O
.	O
5	O
pmol	O
and	O
1	O
pmol	O
.	O

Results	O
in	O
all	O
panels	O
are	O
presented	O
as	O
mean	O
values	O
±	O
SD	O
.	O

Difference	O
between	O
the	O
mouseMitf	B-GP
-	O
3	O
′	O
UTR	O
-	O
luciferase	B-GP
vector	O
with	O
and	O
without	O
co	O
-	O
transfected	O
miRNA	O
was	O
considered	O
statistically	O
significant	O
when	O
p	O
<	O
0	O
.	O
05	O
,	O
shown	O
with	O
an	O
asterisk	O
(	O
T	O
-	O
test	O
,	O
95	O
%	O
confidence	O
level	O
).	O

P	O
-	O
values	O
are	O
presented	O
in	O
Table	O
S1	O
.	O

B	O
.	O

Effects	O
of	O
miRNAs	O
on	O
the	O
mouseMitf	B-GP
-	O
3	O
′	O
UTR	O
-	O
luciferase	B-GP
vector	O
in	O
HEK293	O
cells	O
.	O

Three	O
concentrations	O
of	O
miRNAs	O
were	O
tested	O
:	O
0	O
.	O
1	O
pmol	O
,	O
0	O
.	O
5	O
pmol	O
and	O
1	O
pmol	O
.	O

C	O
.	O

Effects	O
of	O
miRNAs	O
when	O
transfected	O
in	O
combination	O
with	O
another	O
miRNA	O
on	O
the	O
reporter	O
.	O

Concentration	O
of	O
each	O
miRNA	O
is	O
0	O
.	O
5	O
pmol	O
.	O

miR	O
-	O
137	O
and	O
miR	O
-	O
124	O
/	O
506	O
affect	O
mMitf	B-GP
RNA	O
in	O
HEK293	O
cells	O

The	O
luciferase	B-GP
assay	O
experiments	O
were	O
also	O
performed	O
in	O
human	B-OG
embryonic	O
kidney	O
cells	O
(	O
HEK293	O
),	O
which	O
do	O
not	O
express	O
Mitf	B-GP
at	O
significant	O
levels	O
.	O

The	O
effects	O
of	O
the	O
miRNAs	O
in	O
HEK293	O
cells	O
are	O
different	O
from	O
the	O
effects	O
seen	O
in	O
501mel	O
melanoma	B-DS
cells	O
.	O

In	O
HEK293	O
cells	O
the	O
microRNA	O
miR	O
-	O
137	O
negatively	O
affected	O
the	O
mouseMitf	B-GP
-	O
3	O
′	O
UTR	O
-	O
luciferase	B-GP
reporter	O
construct	O
,	O
compared	O
to	O
the	O
reporter	O
construct	O
alone	O
(	O
Fig	O
.	O
2B	O
).	O

miR	O
-	O
148	O
affected	O
the	O
reporter	O
only	O
when	O
transfected	O
at	O
the	O
highest	O
concentration	O
(	O
1pmol	O
)	O
(	O
Fig	O
.	O
2B	O
).	O

miR	O
-	O
124	O
,	O
however	O
resulted	O
in	O
significant	O
increase	O
in	O
reporter	O
gene	O
expression	O
.	O

The	O
other	O
miRNAs	O
tested	O
,	O
miR	O
-	O
27	O
,	O
miR	O
-	O
32	O
and	O
miR	O
-	O
101	O
did	O
not	O
show	O
significant	O
effects	O
on	O
luciferase	B-GP
expression	O
in	O
this	O
assay	O
(	O
Fig	O
.	O
2B	O
).	O

This	O
is	O
surprising	O
as	O
the	O
binding	O
sites	O
for	O
these	O
three	O
miRNAs	O
are	O
very	O
well	O
conserved	O
.	O

All	O
Mitf	B-GP
3	O
′	O
UTR	O
sequences	O
in	O
11	O
vertebrate	O
species	O
analysed	O
contain	O
the	O
miR	O
-	O
27	O
,	O
miR	O
-	O
25	O
/	O
32	O
/	O
92	O
/	O
363	O
/	O
367	O
and	O
the	O
miR	O
-	O
101	O
/	O
144	O
binding	O
sites	O
(	O
Fig	O
.	O
1B	O
).	O

In	O
addition	O
,	O
seven	O
species	O
contain	O
a	O
conserved	O
second	O
miR	O
-	O
101	O
/	O
144	O
binding	O
site	O
.	O

Despite	O
this	O
conservation	O
,	O
these	O
sites	O
do	O
not	O
seem	O
to	O
be	O
regulated	O
by	O
miRNAs	O
in	O
our	O
assays	O
.	O

The	O
different	O
results	O
in	O
melanoma	B-DS
cells	O
as	O
compared	O
to	O
HEK293	O
cells	O
might	O
be	O
explained	O
by	O
different	O
levels	O
of	O
endogenous	O
miRNA	O
expression	O
in	O
these	O
cell	O
types	O
.	O

If	O
one	O
of	O
the	O
miRNAs	O
tested	O
has	O
high	O
endogenous	O
expression	O
in	O
one	O
of	O
the	O
cell	O
types	O
it	O
would	O
affect	O
the	O
expression	O
of	O
the	O
reporter	O
alone	O
.	O

Adding	O
more	O
of	O
the	O
miRNA	O
would	O
presumably	O
not	O
make	O
a	O
major	O
difference	O
.	O

Thus	O
,	O
the	O
effects	O
of	O
the	O
transfected	O
miRNA	O
would	O
be	O
masked	O
by	O
the	O
endogenous	O
expression	O
of	O
the	O
miRNA	O
.	O

Many	O
different	O
miRNAs	O
can	O
bind	O
simultaneously	O
to	O
a	O
specific	O
3	O
′	O
UTR	O
sequence	O
and	O
affect	O
expression	O
.	O

Thus	O
,	O
we	O
tested	O
if	O
transfecting	O
two	O
different	O
miRNAs	O
simultaneously	O
would	O
reveal	O
additive	O
effects	O
.	O

The	O
results	O
are	O
compared	O
to	O
expression	O
by	O
the	O
mouseMitf	B-GP
-	O
3	O
′	O
UTR	O
-	O
luciferase	B-GP
reporter	O
alone	O
.	O

When	O
miR	O
-	O
137	O
was	O
combined	O
with	O
other	O
miRNAs	O
,	O
the	O
effects	O
were	O
always	O
equal	O
to	O
the	O
effects	O
observed	O
with	O
miR	O
-	O
137	O
alone	O
.	O

Also	O
,	O
when	O
miR	O
-	O
124	O
was	O
combined	O
with	O
other	O
miRNAs	O
,	O
the	O
effects	O
were	O
always	O
equal	O
to	O
the	O
effects	O
observed	O
with	O
miR	O
-	O
124	O
alone	O
.	O

When	O
miR	O
-	O
124	O
and	O
miR	O
-	O
137	O
were	O
combined	O
,	O
the	O
same	O
effect	O
was	O
observed	O
as	O
when	O
miR	O
-	O
137	O
was	O
transfected	O
alone	O
(	O
Fig	O
.	O
2C	O
).	O

Other	O
combinations	O
of	O
two	O
miRNAs	O
did	O
not	O
show	O
increased	O
effects	O
.	O

Thus	O
,	O
we	O
detect	O
no	O
cooperation	O
among	O
the	O
miRNA	O
molecules	O
with	O
respect	O
to	O
effects	O
on	O
Mitf	B-GP
.	O

Roles	O
of	O
individual	O
miRNA	O
target	O
sites	O
revealed	O
through	O
mutagenesis	O

To	O
confirm	O
that	O
the	O
miRNAs	O
which	O
show	O
effects	O
on	O
the	O
mouseMitf	B-GP
-	O
3	O
′	O
UTR	O
-	O
luciferase	B-GP
reporter	O
are	O
in	O
fact	O
operating	O
through	O
the	O
predicted	O
potential	O
binding	O
sites	O
,	O
the	O
miRNA	O
binding	O
sites	O
were	O
mutated	O
in	O
the	O
mouseMitf	B-GP
-	O
3	O
′	O
UTR	O
-	O
luciferase	B-GP
vector	O
and	O
the	O
vector	O
then	O
co	O
-	O
transfected	O
into	O
cells	O
together	O
with	O
the	O
specific	O
miRNAs	O
,	O
as	O
before	O
.	O

miRNAs	O
bind	O
to	O
their	O
3	O
′	O
UTR	O
binding	O
site	O
through	O
a	O
seed	O
region	O
located	O
at	O
position	O
2	O
–	O
7	O
or	O
2	O
–	O
8	O
in	O
the	O
mature	O
miRNA	O
sequence	O
[	O
27	O
],	O
[	O
42	O
].	O

We	O
mutated	O
all	O
7	O
bases	O
in	O
the	O
3	O
′	O
UTR	O
binding	O
site	O
matching	O
the	O
seed	O
region	O
of	O
the	O
mature	O
miRNAs	O
in	O
order	O
to	O
abolish	O
completely	O
the	O
binding	O
of	O
the	O
miRNA	O
.	O

In	O
the	O
case	O
of	O
one	O
of	O
the	O
miR	O
-	O
148	O
binding	O
site	O
,	O
148	O
/	O
152A	O
,	O
only	O
4	O
bases	O
were	O
mutated	O
as	O
a	O
clone	O
with	O
the	O
fully	O
mutated	O
binding	O
site	O
was	O
not	O
generated	O
successfully	O
.	O

The	O
mutations	O
are	O
shown	O
in	O
Fig	O
.	O
1C	O
and	O
the	O
primers	O
used	O
for	O
mutagenesis	O
in	O
Table	O
1	O
.	O

Role	O
of	O
the	O
miR	O
-	O
148	O
/	O
152	O
target	O
sites	O

There	O
are	O
two	O
target	O
sites	O
for	O
miR	O
-	O
148	O
/	O
152	O
in	O
the	O
mouse	B-OG
Mitf	B-GP
3	O
′	O
UTR	O
sequence	O
.	O

Each	O
of	O
the	O
two	O
sites	O
were	O
mutated	O
,	O
148	O
/	O
152A	O
located	O
at	O
1674	O
–	O
1680	O
,	O
and	O
148	O
/	O
152B	O
located	O
at	O
2931	O
–	O
2937	O
(	O
Fig	O
1A	O
).	O

In	O
these	O
experiments	O
,	O
we	O
define	O
the	O
expression	O
level	O
of	O
the	O
vector	O
alone	O
as	O
100	O
%.	O

When	O
determining	O
how	O
effective	O
each	O
mutation	O
was	O
in	O
our	O
assays	O
,	O
expression	O
of	O
luciferase	B-GP
from	O
the	O
mutated	O
vector	O
alone	O
was	O
compared	O
to	O
expression	O
from	O
the	O
mutated	O
vector	O
when	O
co	O
-	O
transfected	O
with	O
the	O
appropriate	O
miRNA	O
.	O

When	O
both	O
binding	O
sites	O
were	O
functional	O
miR	O
-	O
148	O
downregulated	O
reporter	O
gene	O
expression	O
to	O
50	O
–	O
60	O
%	O
compared	O
to	O
expression	O
from	O
the	O
vector	O
alone	O
in	O
501mel	O
cells	O
(	O
p	O
=	O
0	O
.	O
0140	O
)	O
(	O
Fig	O
.	O
3A	O
).	O

When	O
the	O
148	O
/	O
152A	O
binding	O
site	O
was	O
mutated	O
,	O
miR	O
-	O
148	O
downregulated	O
reporter	O
gene	O
expression	O
to	O
47	O
%	O
(	O
p	O
=	O
0	O
.	O
0049	O
).	O

However	O
,	O
when	O
the	O
148	O
/	O
152B	O
binding	O
site	O
was	O
mutated	O
,	O
miR	O
-	O
148	O
was	O
no	O
longer	O
able	O
to	O
downregulate	O
reporter	O
gene	O
expression	O
(	O
p	O
=	O
0	O
.	O
3929	O
).	O

When	O
both	O
binding	O
sites	O
were	O
mutated	O
,	O
reporter	O
gene	O
expression	O
was	O
the	O
same	O
as	O
when	O
148	O
/	O
152B	O
was	O
mutated	O
(	O
118	O
%,	O
p	O
=	O
0	O
.	O
4918	O
).	O

These	O
results	O
indicate	O
that	O
miR	O
-	O
148	O
is	O
able	O
to	O
downregulate	O
Mitf	B-GP
expression	O
by	O
binding	O
to	O
the	O
148	O
/	O
152B	O
binding	O
site	O
.	O

Mutating	O
miRNA	O
binding	O
sites	O
affects	O
the	O
Mitf	B-GP
mRNA	O
.	O

A	O
.	O

Effects	O
of	O
miR	O
-	O
148	O
on	O
the	O
mouseMitf	B-GP
-	O
3	O
′	O
UTR	O
-	O
luciferase	B-GP
reporter	O
when	O
the	O
potential	O
binding	O
sites	O
are	O
mutated	O
.	O

Results	O
in	O
all	O
panels	O
are	O
presented	O
as	O
mean	O
values	O
±	O
SD	O
.	O

Difference	O
between	O
the	O
appropriate	O
vector	O
(	O
labeled	O
on	O
the	O
X	O
-	O
axis	O
)	O
with	O
and	O
without	O
co	O
-	O
transfected	O
miRNA	O
was	O
considered	O
statistically	O
significant	O
when	O
p	O
<	O
0	O
.	O
05	O
,	O
shown	O
with	O
an	O
asterisk	O
(	O
T	O
-	O
test	O
,	O
95	O
%	O
confidence	O
level	O
).	O

P	O
-	O
values	O
are	O
presented	O
in	O
Table	O
S1	O
.	O

B	O
.	O

Effects	O
of	O
miR	O
-	O
137	O
on	O
the	O
mouseMitf	B-GP
-	O
3	O
′	O
UTR	O
-	O
luciferase	B-GP
reporter	O
when	O
the	O
potential	O
binding	O
sites	O
are	O
mutated	O
.	O

C	O
.	O

Effects	O
of	O
miR	O
-	O
124	O
on	O
the	O
mouseMitf	B-GP
-	O
3	O
′	O
UTR	O
-	O
luciferase	B-GP
reporter	O
when	O
the	O
potential	O
binding	O
sites	O
are	O
mutated	O
.	O

Role	O
of	O
the	O
miR	O
-	O
137	O
target	O
sites	O

The	O
four	O
target	O
sites	O
for	O
miR	O
-	O
137	O
in	O
the	O
Mitf	B-GP
3	O
′	O
UTR	O
sequence	O
,	O
137A	O
(	O
2495	O
–	O
2501	O
),	O
137B	O
(	O
2782	O
–	O
2788	O
),	O
137C	O
(	O
2842	O
–	O
2848	O
)	O
and	O
137D	O
(	O
3061	O
–	O
3067	O
)	O
were	O
mutated	O
seperatly	O
.	O

In	O
addition	O
,	O
a	O
double	O
mutant	O
was	O
created	O
where	O
the	O
most	O
conserved	O
sites	O
137C	O
and	O
137D	O
were	O
changed	O
simultaneously	O
,	O
a	O
triple	O
mutant	O
with	O
137B	O
,	O
137C	O
and	O
137D	O
mutated	O
and	O
a	O
mutant	O
where	O
all	O
four	O
potential	O
binding	O
sites	O
were	O
changed	O
(	O
Fig	O
.	O
1C	O
).	O

The	O
mutated	O
mouseMitf	B-GP
-	O
3	O
′	O
UTR	O
-	O
luciferase	B-GP
constructs	O
were	O
co	O
-	O
transfected	O
together	O
with	O
the	O
miRNAs	O
in	O
HEK293	O
cells	O
.	O

When	O
all	O
the	O
miR	O
-	O
137	O
binding	O
sites	O
are	O
functional	O
,	O
miR	O
-	O
137	O
reduced	O
expression	O
from	O
the	O
luciferase	B-GP
reporter	O
to	O
only	O
10	O
%	O
(	O
p	O
=	O
0	O
.	O
0015	O
)	O
compared	O
to	O
the	O
vector	O
alone	O
(	O
Fig	O
.	O
3B	O
).	O

When	O
miR	O
-	O
137	O
was	O
co	O
-	O
transfected	O
with	O
a	O
reporter	O
construct	O
containing	O
the	O
mutant	O
site	O
137A	O
,	O
expression	O
from	O
the	O
luciferase	B-GP
reporter	O
was	O
7	O
%	O
compared	O
to	O
the	O
vector	O
alone	O
(	O
p	O
<	O
0	O
.	O
0001	O
).	O

This	O
is	O
similar	O
reduction	O
as	O
was	O
seen	O
with	O
the	O
wild	O
type	O
construct	O
,	O
suggesting	O
that	O
this	O
site	O
has	O
no	O
role	O
in	O
the	O
response	O
to	O
miR	O
-	O
137	O
(	O
Fig	O
.	O
3B	O
).	O

Mutating	O
the	O
137B	O
site	O
resulted	O
in	O
16	O
%	O
expression	O
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
which	O
is	O
a	O
little	O
less	O
reduction	O
than	O
was	O
seen	O
when	O
all	O
the	O
potential	O
binding	O
sites	O
were	O
functional	O
.	O

When	O
the	O
more	O
conserved	O
site	O
137C	O
was	O
mutated	O
,	O
expression	O
from	O
the	O
mouseMitf	B-GP
-	O
3	O
′	O
UTR	O
-	O
luciferase	B-GP
reporter	O
was	O
reduced	O
to	O
19	O
%	O
(	O
p	O
=	O
0	O
.	O
0001	O
)	O
(	O
Fig	O
.	O
3B	O
),	O
indicating	O
a	O
functional	O
role	O
of	O
miR	O
-	O
137C	O
.	O

Mutating	O
the	O
other	O
well	O
conserved	O
binding	O
site	O
137D	O
resulted	O
in	O
reduction	O
to	O
23	O
%	O
expression	O
(	O
p	O
=	O
0	O
.	O
0001	O
)	O
of	O
the	O
mutated	O
mouseMitf	B-GP
-	O
3	O
′	O
UTR	O
-	O
luciferase	B-GP
reporter	O
(	O
Fig	O
.	O
3B	O
),	O
again	O
indicating	O
a	O
functional	O
target	O
site	O
.	O

When	O
the	O
two	O
best	O
conserved	O
binding	O
sites	O
(	O
137C	O
and	O
137D	O
)	O
were	O
simultaneously	O
mutated	O
,	O
reporter	O
expression	O
was	O
32	O
%	O
(	O
p	O
=	O
0	O
.	O
0001	O
)	O
compared	O
to	O
expression	O
from	O
the	O
mutated	O
vector	O
alone	O
,	O
suggesting	O
that	O
sites	O
C	O
and	O
D	O
play	O
a	O
major	O
role	O
in	O
the	O
response	O
to	O
miR	O
-	O
137	O
.	O

Surprisingly	O
,	O
when	O
miR	O
-	O
137	O
was	O
co	O
-	O
transfected	O
with	O
a	O
reporter	O
construct	O
lacking	O
the	O
3	O
′	O
UTR	O
sequence	O
of	O
Mitf	B-GP
,	O
miR	O
-	O
137	O
downregulated	O
luciferase	B-GP
expression	O
to	O
27	O
%	O
(	O
Fig	O
.	O
3B	O
).	O

This	O
suggests	O
that	O
the	O
luciferase	B-GP
vector	O
has	O
binding	O
sites	O
for	O
miR	O
-	O
137	O
.	O

Indeed	O
,	O
our	O
search	O
for	O
miR	O
-	O
137	O
binding	O
sites	O
in	O
the	O
luciferase	B-GP
gene	O
itself	O
resulted	O
in	O
3	O
matching	O
sequences	O
.	O

There	O
are	O
reports	O
showing	O
that	O
binding	O
sites	O
within	O
the	O
coding	O
regions	O
of	O
genes	O
can	O
result	O
in	O
effects	O
on	O
gene	O
expression	O
[	O
43	O
].	O

It	O
is	O
also	O
possible	O
that	O
the	O
miR	O
-	O
137	O
is	O
affecting	O
other	O
components	O
(	O
genes	O
/	O
transcripts	O
)	O
that	O
are	O
involved	O
in	O
the	O
transcription	O
of	O
the	O
luciferase	B-GP
gene	O
.	O

Thus	O
,	O
when	O
sites	O
137C	O
and	O
137D	O
were	O
mutated	O
simultaneously	O
,	O
the	O
expression	O
of	O
the	O
reporter	O
was	O
reduced	O
to	O
32	O
%	O
which	O
is	O
very	O
similar	O
to	O
the	O
level	O
of	O
expression	O
when	O
all	O
miR	O
-	O
137	O
binding	O
sites	O
are	O
funcional	O
(	O
27	O
%),	O
suggesting	O
that	O
all	O
the	O
effects	O
of	O
miR	O
-	O
137	O
on	O
the	O
mouseMitf	B-GP
-	O
3	O
′	O
UTR	O
-	O
luciferase	B-GP
are	O
mediated	O
through	O
these	O
two	O
sites	O
.	O

When	O
three	O
or	O
all	O
four	O
miR	O
-	O
137	O
binding	O
sites	O
were	O
mutated	O
simultaneously	O
,	O
the	O
mutated	O
vector	O
alone	O
was	O
unable	O
to	O
express	O
the	O
luciferase	B-GP
gene	O
(	O
data	O
not	O
shown	O
).	O

One	O
possible	O
explanation	O
for	O
this	O
might	O
be	O
that	O
the	O
structure	O
of	O
the	O
3	O
′	O
UTR	O
is	O
altered	O
when	O
21	O
or	O
28	O
conserved	O
bases	O
are	O
mutated	O
,	O
leading	O
to	O
reduced	O
stability	O
or	O
effects	O
on	O
translation	O
of	O
the	O
message	O
.	O

miR	O
-	O
137	O
has	O
previously	O
been	O
shown	O
to	O
target	O
Mitf	B-GP
by	O
acting	O
through	O
the	O
best	O
conserved	O
miR	O
-	O
137	O
target	O
sites	O
[	O
31	O
].	O

However	O
,	O
in	O
that	O
study	O
,	O
only	O
a	O
portion	O
of	O
the	O
Mitf	B-GP
3	O
′	O
UTR	O
sequence	O
was	O
used	O
in	O
the	O
analysis	O
[	O
31	O
].	O

In	O
our	O
analysis	O
,	O
however	O
,	O
the	O
entire	O
3	O
′	O
UTR	O
sequence	O
from	O
mouse	B-OG
Mitf	B-GP
(	O
over	O
3	O
kb	O
)	O
was	O
used	O
to	O
analyse	O
the	O
role	O
of	O
the	O
binding	O
sites	O
.	O

This	O
more	O
closely	O
resembles	O
the	O
endogenous	O
situation	O
.	O

Our	O
results	O
therefore	O
confirm	O
the	O
role	O
of	O
miR	O
-	O
137	O
in	O
regulating	O
Mitf	B-GP
expression	O
.	O

Role	O
of	O
the	O
miR	O
-	O
124	O
/	O
506	O
target	O
sites	O

There	O
are	O
two	O
binding	O
sites	O
for	O
miR	O
-	O
124	O
/	O
506	O
in	O
the	O
mouse	B-OG
Mitf	B-GP
3	O
′	O
UTR	O
sequence	O
.	O

Site	O
124	O
/	O
506A	O
is	O
located	O
at	O
548	O
-	O
554	O
and	O
site	O
124	O
/	O
506B	O
at	O
1639	O
-	O
1646	O
in	O
the	O
mMitf	B-GP
3	O
′	O
UTR	O
sequence	O
.	O

When	O
both	O
binding	O
sites	O
are	O
functional	O
,	O
miR	O
-	O
124	O
positively	O
affects	O
luciferase	B-GP
expression	O
up	O
to	O
3	O
fold	O
compared	O
to	O
expression	O
from	O
the	O
vector	O
alone	O
in	O
HEK293	O
cells	O
(	O
p	O
=	O
0	O
.	O
0086	O
)	O
(	O
Fig	O
.	O
3C	O
).	O

We	O
mutated	O
each	O
target	O
site	O
alone	O
and	O
also	O
made	O
a	O
double	O
mutation	O
changing	O
both	O
sites	O
.	O

When	O
the	O
124	O
/	O
506A	O
binding	O
site	O
was	O
mutated	O
,	O
miR	O
-	O
124	O
no	O
longer	O
affected	O
expression	O
of	O
the	O
reporter	O
gene	O
.	O

The	O
expression	O
was	O
only	O
81	O
%	O
compared	O
to	O
315	O
%	O
in	O
the	O
vector	O
alone	O
(	O
P	O
=	O
0	O
.	O
1376	O
).	O

When	O
the	O
124	O
/	O
506B	O
binding	O
site	O
was	O
mutated	O
,	O
miR	O
-	O
124	O
still	O
upregulated	O
lucifease	O
expression	O
to	O
240	O
%	O
(	O
p	O
=	O
0	O
.	O
0030	O
).	O

When	O
both	O
binding	O
sites	O
were	O
mutated	O
,	O
miR	O
-	O
124	O
did	O
not	O
result	O
in	O
increased	O
expression	O
of	O
the	O
luciferase	B-GP
reporter	O
,	O
at	O
least	O
not	O
as	O
effectively	O
as	O
when	O
both	O
potential	O
binding	O
sites	O
were	O
functional	O
(	O
146	O
%	O
expression	O
,	O
p	O
=	O
0	O
.	O
1864	O
).	O

These	O
results	O
suggest	O
that	O
miR	O
-	O
124	O
leads	O
to	O
positive	O
effects	O
on	O
the	O
Mitf	B-GP
mRNA	O
by	O
binding	O
to	O
the	O
124	O
/	O
506A	O
binding	O
site	O
.	O

At	O
present	O
,	O
it	O
is	O
not	O
clear	O
how	O
miR	O
-	O
124	O
mediates	O
this	O
upregulation	O
.	O

The	O
effects	O
of	O
miR	O
-	O
506	O
,	O
that	O
binds	O
to	O
the	O
same	O
target	O
site	O
,	O
were	O
not	O
tested	O
.	O

miR	O
-	O
148	O
and	O
miR	O
-	O
137	O
affect	O
expression	O
of	O
the	O
endogenous	O
MITF	B-GP

In	O
order	O
to	O
test	O
if	O
these	O
miRNAs	O
affect	O
the	O
level	O
of	O
endogenous	O
MITF	B-GP
mRNA	O
in	O
melanoma	B-DS
cells	O
,	O
we	O
used	O
qRT	O
-	O
PCR	O
to	O
determine	O
MITF	B-GP
mRNA	O
expression	O
after	O
transfecting	O
MeWo	O
melanoma	B-DS
cells	O
with	O
the	O
miRNAs	O
miR	O
-	O
124	O
,	O
miR	O
-	O
137	O
and	O
miR	O
-	O
148	O
.	O

MeWo	O
cells	O
express	O
less	O
MITF	B-GP
than	O
the	O
501mel	O
cells	O
used	O
previously	O
.	O

Therefore	O
,	O
the	O
difference	O
in	O
expression	O
upon	O
treatment	O
was	O
more	O
easily	O
detected	O
with	O
the	O
amount	O
of	O
miRNA	O
used	O
.	O

The	O
results	O
,	O
normalized	O
to	O
total	O
RNA	O
,	O
are	O
shown	O
in	O
Fig	O
.	O
4A	O
and	O
confirm	O
our	O
previous	O
findings	O
.	O

When	O
miR	O
-	O
137	O
was	O
transfected	O
into	O
MeWo	O
cells	O
,	O
the	O
level	O
of	O
MITF	B-GP
mRNA	O
was	O
reduced	O
to	O
68	O
%	O
(	O
Cp	O
value	O
22	O
.	O
3	O
,	O
p	O
=	O
0	O
.	O
0069	O
)	O
compared	O
to	O
100	O
%	O
in	O
untreated	O
cells	O
(	O
No	O
-	O
miR	O
,	O
Cp	O
value	O
21	O
.	O
7	O
).	O

Similarily	O
,	O
when	O
miR	O
-	O
148	O
was	O
transfected	O
into	O
these	O
cells	O
,	O
MITF	B-GP
mRNA	O
level	O
was	O
reduced	O
to	O
48	O
%	O
(	O
Cp	O
value	O
22	O
.	O
8	O
,	O
p	O
=	O
0	O
.	O
0051	O
)	O
compared	O
to	O
untreated	O
cells	O
.	O

Simultaneous	O
transfection	O
with	O
miR	O
-	O
137	O
and	O
miR	O
-	O
148	O
did	O
not	O
result	O
in	O
further	O
effects	O
on	O
MITF	B-GP
expression	O
as	O
it	O
reduced	O
expression	O
to	O
67	O
%	O
(	O
Cp	O
value	O
22	O
.	O
3	O
,	O
p	O
=	O
0	O
.	O
0051	O
),	O
which	O
is	O
similar	O
to	O
the	O
reduction	O
seen	O
with	O
miR	O
-	O
137	O
alone	O
(	O
Fig	O
.	O
4A	O
).	O

Thus	O
,	O
these	O
miRNAs	O
do	O
not	O
seem	O
to	O
work	O
synergistically	O
in	O
downregulating	O
MITF	B-GP
.	O

Effects	O
of	O
miRNAs	O
on	O
endogenous	O
MITF	B-GP
.	O

A	O
.	O

Expression	O
of	O
human	B-OG
MITF	B-GP
mRNA	O
in	O
MeWo	O
cells	O
transfected	O
with	O
miR	O
-	O
124	O
,	O
miR	O
-	O
137	O
,	O
miR	O
-	O
148	O
or	O
miR	O
-	O
137	O
and	O
miR	O
-	O
148	O
combined	O
.	O

The	O
figure	O
shows	O
average	O
expression	O
levels	O
of	O
three	O
replicates	O
for	O
each	O
sample	O
relative	O
to	O
untreated	O
cells	O
(	O
No	O
-	O
miR	O
).	O

Negative	O
control	O
is	O
a	O
scramble	O
miRNA	O
sequence	O
(	O
scramble	O
).	O

Statistically	O
significant	O
difference	O
between	O
untreated	O
cells	O
and	O
treated	O
cells	O
are	O
shown	O
with	O
an	O
asterisk	O
(	O
T	O
-	O
test	O
,	O
95	O
%	O
confidence	O
level	O
).	O

P	O
-	O
values	O
are	O
:	O
Scramble	O
=	O
0	O
.	O
0396	O
;	O
miR	O
-	O
124	O
=	O
0	O
.	O
2228	O
;	O
miR	O
-	O
137	O
=	O
0	O
.	O
0069	O
;	O
miR	O
-	O
148	O
=	O
0	O
.	O
0051	O
;	O
miR	O
-	O
137	O
+	O
148	O
=	O
0	O
.	O
0051	O
.	O

B	O
.	O

Western	O
blot	O
analysis	O
on	O
MITF	B-GP
protein	O
levels	O
in	O
MeWo	O
cells	O
,	O
when	O
transfected	O
with	O
miR	O
-	O
124	O
,	O
miR	O
-	O
137	O
,	O
miR	O
-	O
148	O
or	O
miR	O
-	O
137	O
and	O
miR	O
-	O
148	O
combined	O
.	O

Similar	O
to	O
what	O
we	O
observed	O
using	O
the	O
luciferase	B-GP
-	O
reporter	O
assay	O
,	O
miR	O
-	O
124	O
was	O
able	O
to	O
upregulate	O
MITF	B-GP
expression	O
in	O
the	O
MeWo	O
cells	O
.	O

The	O
expression	O
was	O
increased	O
to	O
122	O
%	O
(	O
Cp	O
value	O
21	O
.	O
5	O
)	O
compared	O
to	O
untreated	O
cells	O
;	O
however	O
,	O
this	O
difference	O
is	O
not	O
statistically	O
significant	O
(	O
p	O
=	O
0	O
.	O
2228	O
).	O

The	O
same	O
experiment	O
was	O
performed	O
once	O
in	O
501mel	O
cells	O
,	O
the	O
only	O
signifant	O
downregulation	O
was	O
by	O
miR	O
-	O
137	O
when	O
compared	O
to	O
transfection	O
with	O
a	O
scramble	O
miRNA	O
(	O
data	O
not	O
shown	O
).	O

These	O
results	O
show	O
that	O
the	O
miR	O
-	O
137	O
and	O
miR	O
-	O
148	O
have	O
the	O
same	O
effects	O
on	O
expression	O
of	O
the	O
endogenous	O
MITF	B-GP
gene	O
as	O
seen	O
using	O
the	O
luciferase	B-GP
reporter	O
assay	O
.	O

The	O
effects	O
of	O
miRNAs	O
on	O
MITF	B-GP
protein	O
level	O
were	O
also	O
tested	O
in	O
MeWo	O
cells	O
and	O
confirmed	O
our	O
previous	O
findings	O
(	O
Fig	O
.	O
4B	O
).	O

When	O
the	O
cells	O
were	O
transfected	O
with	O
either	O
miR	O
-	O
137	O
,	O
miR	O
-	O
148	O
or	O
simultaneously	O
with	O
both	O
miR	O
-	O
137	O
and	O
miR	O
-	O
148	O
,	O
MITF	B-GP
protein	O
levels	O
were	O
reduced	O
.	O

Also	O
,	O
when	O
miR	O
-	O
124	O
was	O
transfected	O
,	O
higher	O
MITF	B-GP
protein	O
levels	O
were	O
observed	O
(	O
Fig	O
.	O
4B	O
).	O

In	O
order	O
to	O
test	O
the	O
specificity	O
of	O
the	O
miRNAs	O
,	O
we	O
used	O
specific	O
anti	O
-	O
miRNAs	O
to	O
inhibit	O
the	O
effects	O
of	O
the	O
miRNAs	O
used	O
in	O
our	O
experiments	O
.	O

Consistent	O
with	O
previous	O
results	O
,	O
cells	O
simultaneously	O
transfected	O
with	O
the	O
luciferase	B-GP
vector	O
construct	O
,	O
the	O
miR	O
-	O
148	O
and	O
the	O
anti	O
-	O
miR	O
-	O
148	O
showed	O
that	O
the	O
anti	O
-	O
miR148	O
molecule	O
effectively	O
inhibited	O
the	O
effects	O
of	O
miR	O
-	O
148	O
(	O
Fig	O
.	O
5A	O
).	O

Similarly	O
,	O
the	O
effects	O
of	O
miR	O
-	O
137	O
and	O
miR	O
-	O
148	O
on	O
endogenous	O
MITF	B-GP
mRNAs	O
are	O
inhibited	O
when	O
MeWo	O
cells	O
were	O
co	O
-	O
transfected	O
with	O
anti	O
-	O
miRNAs	O
(	O
Fig	O
.	O
5B	O
).	O

These	O
results	O
further	O
verifies	O
that	O
the	O
effects	O
on	O
Mitf	B-GP
mRNA	O
are	O
specific	O
to	O
these	O
microRNAs	O
.	O

Inhibiting	O
the	O
miRNAs	O
blocks	O
their	O
effect	O
.	O

A	O
.	O

Co	O
-	O
transfection	O
of	O
anti	O
-	O
miR	O
-	O
148	O
and	O
miR	O
-	O
148	O
simultaneously	O
with	O
the	O
Mitf	B-GP
-	O
3	O
′	O
UTR	O
-	O
luciferase	B-GP
vector	O
inhibits	O
the	O
effect	O
of	O
miR	O
-	O
148	O
.	O

Results	O
are	O
presented	O
as	O
mean	O
values	O
±	O
SD	O
.	O

Expression	O
levels	O
were	O
compared	O
to	O
a	O
sample	O
where	O
no	O
microRNAs	O
were	O
added	O
(	O
No	O
-	O
miR	O
)	O
and	O
were	O
considered	O
statistically	O
significant	O
when	O
p	O
<	O
0	O
.	O
05	O
,	O
shown	O
with	O
an	O
asterisk	O
(	O
T	O
-	O
test	O
,	O
95	O
%	O
confidence	O
level	O
).	O

The	O
p	O
-	O
values	O
are	O
;	O
miR	O
-	O
neg	O
=	O
0	O
.	O
14	O
miR	O
-	O
148	O
=	O
0	O
.	O
007	O
,	O
miR	O
-	O
148	O
+	O
anti	O
-	O
miR	O
-	O
148	O
=	O
0	O
.	O
119	O
.	O

B	O
.	O

Transfecting	O
miRNAs	O
and	O
anti	O
-	O
miRNAs	O
blocked	O
the	O
effect	O
of	O
the	O
miRNAs	O
on	O
endogenous	O
human	B-OG
MITF	B-GP
mRNA	O
levels	O
in	O
MeWo	O
cells	O
.	O

P	O
-	O
values	O
when	O
compared	O
to	O
the	O
no	O
-	O
miR	O
sample	O
are	O
:	O
Neg	O
control	O
=	O
0	O
.	O
064	O
,	O
miR	O
-	O
137	O
=	O
0	O
.	O
006	O
,	O
miR	O
-	O
137	O
+	O
anti	O
-	O
miR	O
-	O
137	O
=	O
0	O
.	O
854	O
,	O
miR	O
-	O
148	O
=	O
0	O
.	O
004	O
,	O
miR	O
-	O
148	O
+	O
anti	O
-	O
miR	O
-	O
148	O
=	O
0	O
.	O
632	O
.	O

Endogenous	O
miRNA	O
expression	O

The	O
expression	O
of	O
miRNAs	O
137	O
,	O
124	O
,	O
506	O
,	O
148a	O
,	O
148b	O
and	O
152	O
was	O
determined	O
in	O
the	O
HEK293	O
,	O
501mel	O
and	O
MeWo	O
cell	O
lines	O
.	O

The	O
expression	O
of	O
the	O
miRNAs	O
was	O
measured	O
using	O
the	O
MiRcury	O
LNA	O
Universal	O
RT	O
microRNA	O
PCR	O
method	O
.	O

An	O
RNA	O
pool	O
from	O
20	O
different	O
tissues	O
was	O
used	O
as	O
a	O
positive	O
control	O
and	O
the	O
results	O
were	O
normalized	O
to	O
the	O
expression	O
of	O
miR	O
-	O
16	O
and	O
miR	O
-	O
103	O
.	O

Cp	O
values	O
(	O
crossing	O
point	O
)	O
are	O
shown	O
in	O
Table	O
2	O
.	O

Cp	O
values	O
for	O
determining	O
endogenous	O
miRNA	O
expression	O
.	O

miRNA	O

HEK293	O

501mel	O

MeWo	O

Positive	O
contr	O
.	O

miR	O
-	O
137	O

ND	O
(	O
1	O
/	O
9	O
)	O

ND	O
(	O
0	O
/	O
9	O
)	O

34	O
.	O
69	O
(	O
7	O
/	O
9	O
)	O

37	O
.	O
39	O
(	O
1	O
/	O
3	O
)	O

miR	O
-	O
124	O

34	O
.	O
37	O
(	O
9	O
/	O
9	O
)	O

34	O
.	O
73	O
(	O
5	O
/	O
9	O
)	O

35	O
.	O
09	O
(	O
2	O
/	O
9	O
)	O

32	O
.	O
68	O
(	O
3	O
/	O
3	O
)	O

miR	O
-	O
506	O

35	O
.	O
19	O
(	O
2	O
/	O
9	O
)	O

34	O
.	O
73	O
(	O
3	O
/	O
9	O
)	O

32	O
.	O
87	O
(	O
9	O
/	O
9	O
)	O

ND	O
(	O
0	O
/	O
9	O
)	O

miR	O
-	O
148a	O

27	O
.	O
90	O
(	O
9	O
/	O
9	O
)	O

28	O
.	O
29	O
(	O
9	O
/	O
9	O
)	O

28	O
.	O
82	O
(	O
9	O
/	O
9	O
)	O

33	O
.	O
12	O
(	O
3	O
/	O
3	O
)	O

miR	O
-	O
148b	O

28	O
.	O
37	O
(	O
9	O
/	O
9	O
)	O

28	O
.	O
65	O
(	O
9	O
/	O
9	O
)	O

29	O
.	O
37	O
(	O
9	O
/	O
9	O
)	O

35	O
.	O
19	O
(	O
1	O
/	O
3	O
)	O

miR	O
-	O
152	O

34	O
.	O
08	O
(	O
9	O
/	O
9	O
)	O

35	O
.	O
12	O
(	O
9	O
/	O
9	O
)	O

34	O
.	O
26	O
(	O
9	O
/	O
9	O
)	O

35	O
.	O
05	O
(	O
2	O
/	O
3	O
)	O

miR	O
-	O
16	O
contr	O
.	O

26	O
.	O
19	O
(	O
9	O
/	O
9	O
)	O

25	O
.	O
72	O
(	O
9	O
/	O
9	O
)	O

25	O
.	O
92	O
(	O
9	O
/	O
9	O
)	O

31	O
.	O
83	O
(	O
3	O
/	O
3	O
)	O

miR	O
-	O
103	O
contr	O
.	O

27	O
.	O
07	O
(	O
9	O
/	O
9	O
)	O

26	O
.	O
76	O
(	O
9	O
/	O
9	O
)	O

27	O
.	O
81	O
(	O
9	O
/	O
9	O
)	O

33	O
.	O
09	O
(	O
3	O
/	O
3	O
)	O

Cp	O
values	O
for	O
average	O
normalised	O
values	O
are	O
shown	O
for	O
each	O
miRNA	O
tested	O
in	O
HEK293	O
,	O
501mel	O
and	O
MeWo	O
cells	O
as	O
well	O
as	O
the	O
positive	O
control	O
.	O

Each	O
assay	O
was	O
preformed	O
in	O
triplicate	O
for	O
three	O
RNA	O
samples	O
from	O
each	O
cell	O
type	O
.	O

The	O
number	O
of	O
samples	O
that	O
each	O
miRNA	O
was	O
detected	O
in	O
,	O
is	O
shown	O
in	O
parenthesis	O
.	O

ND	O
=	O
not	O
detected	O
.	O

miR	O
-	O
148	O
and	O
miR	O
-	O
152	O

The	O
microRNAs	O
miR	O
-	O
148a	O
and	O
miR	O
-	O
148b	O
have	O
similar	O
expression	O
levels	O
in	O
all	O
the	O
cell	O
types	O
tested	O
.	O

Expression	O
in	O
the	O
melanoma	B-DS
cell	O
lines	O
501mel	O
and	O
MeWo	O
was	O
around	O
1	O
.	O
5	O
fold	O
less	O
than	O
expression	O
in	O
HEK293	O
cells	O
(	O
Fig	O
.	O
6	O
).	O

Higher	O
endogenous	O
expression	O
in	O
HEK293	O
cells	O
might	O
explain	O
why	O
transfected	O
miR	O
-	O
148	O
had	O
no	O
effect	O
on	O
reporter	O
gene	O
expression	O
in	O
HEK293	O
cells	O
,	O
except	O
at	O
the	O
highest	O
concentration	O
.	O

miR	O
-	O
148	O
affected	O
reporter	O
gene	O
expression	O
more	O
significantly	O
in	O
501mel	O
cells	O
.	O

Expression	O
of	O
miR	O
-	O
152	O
in	O
501mel	O
was	O
2	O
.	O
7	O
fold	O
lower	O
than	O
in	O
HEK293	O
cells	O
and	O
was	O
much	O
lower	O
then	O
the	O
expression	O
of	O
miR	O
-	O
148a	O
and	O
miR	O
-	O
148b	O
in	O
all	O
cell	O
types	O
(	O
see	O
Table	O
2	O
).	O

Low	O
expression	O
of	O
miR	O
-	O
148a	O
,	O
148b	O
and	O
152	O
in	O
the	O
melanoma	B-DS
cell	O
lines	O
is	O
therefore	O
consistent	O
with	O
the	O
relatively	O
high	O
level	O
of	O
MITF	B-GP
expression	O
in	O
these	O
cells	O
.	O

Endogenous	O
miRNA	O
expression	O
.	O

Expression	O
of	O
endogenous	O
miRNAs	O
miR	O
-	O
148a	O
,	O
miR	O
-	O
148b	O
and	O
miR	O
-	O
152	O
in	O
HEK293	O
,	O
501mel	O
and	O
MeWo	O
cells	O
.	O

The	O
figure	O
shows	O
average	O
expression	O
levels	O
of	O
three	O
replicates	O
for	O
each	O
sample	O
relative	O
to	O
HEK293	O
cells	O
.	O

Expression	O
was	O
normalized	O
to	O
miR	O
-	O
16	O
and	O
miR	O
-	O
103	O
.	O

Statistically	O
significant	O
levels	O
of	O
expression	O
in	O
MeWo	O
and	O
501mel	O
compared	O
to	O
HEK293	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
are	O
shown	O
with	O
an	O
asterisk	O
.	O

P	O
-	O
values	O
are	O
:	O
miR	O
-	O
148a	O
expression	O
in	O
501mel	O
=	O
0	O
.	O
0940	O
and	O
in	O
MeWo	O
=	O
0	O
.	O
0148	O
.	O

miR	O
-	O
148b	O
expression	O
in	O
501mel	O
=	O
0	O
.	O
0023	O
and	O
in	O
MeWo	O
=	O
0	O
.	O
0065	O
.	O

miR	O
-	O
152	O
expression	O
in	O
501mel	O
=	O
0	O
.	O
0054	O
and	O
in	O
MeWo	O
=	O
0	O
.	O
9316	O
.	O

miR	O
-	O
137	O

Endogenous	O
miR	O
-	O
137	O
was	O
only	O
detected	O
in	O
MeWo	O
cells	O
,	O
not	O
in	O
HEK293	O
,	O
501mel	O
or	O
the	O
positive	O
control	O
.	O

Expression	O
in	O
the	O
MeWo	O
cells	O
,	O
although	O
at	O
rather	O
low	O
levels	O
(	O
average	O
Cp	O
value	O
34	O
.	O
7	O
compared	O
to	O
the	O
controls	O
(	O
miR	O
-	O
16	O
and	O
103	O
)	O
at	O
25	O
.	O
9	O
and	O
27	O
.	O
8	O
respectively	O
),	O
indicates	O
possible	O
involvement	O
in	O
regulating	O
the	O
endogenous	O
levels	O
of	O
MITF	B-GP
in	O
this	O
cell	O
type	O
.	O
MITF	B-GP
is	O
expressed	O
in	O
MeWo	O
cells	O
but	O
at	O
a	O
lower	O
level	O
than	O
in	O
501mel	O
cells	O
which	O
is	O
consistent	O
with	O
the	O
expression	O
of	O
miR	O
-	O
137	O
in	O
MeWo	O
cells	O
and	O
its	O
absence	O
in	O
501mel	O
cells	O
.	O

miR	O
-	O
137	O
affected	O
reporter	O
gene	O
expression	O
in	O
HEK293	O
cells	O
,	O
which	O
is	O
in	O
line	O
with	O
the	O
absence	O
of	O
endogenous	O
miR	O
-	O
137	O
in	O
this	O
cell	O
type	O
.	O

It	O
is	O
unclear	O
why	O
transfected	O
miR	O
-	O
137	O
did	O
not	O
affect	O
reporter	O
gene	O
expression	O
in	O
501mel	O
cells	O
where	O
endogenous	O
miR	O
-	O
137	O
was	O
not	O
detected	O
.	O

The	O
absence	O
of	O
miR	O
-	O
137	O
in	O
501mel	O
cells	O
might	O
be	O
explained	O
by	O
mutations	O
in	O
the	O
miR	O
-	O
137	O
gene	O
itself	O
as	O
has	O
been	O
shown	O
to	O
be	O
the	O
case	O
in	O
other	O
melanoma	B-DS
cells	O
[	O
31	O
],	O
thus	O
allowing	O
high	O
levels	O
of	O
MITF	B-GP
expression	O
.	O

miR	O
-	O
124	O
and	O
miR	O
-	O
506	O

The	O
level	O
of	O
miR	O
-	O
124	O
expression	O
was	O
considered	O
to	O
be	O
too	O
low	O
to	O
be	O
detected	O
in	O
all	O
cell	O
types	O
.	O

We	O
therefore	O
can	O
not	O
definitely	O
conclude	O
anything	O
about	O
the	O
expression	O
of	O
miR	O
-	O
124	O
in	O
our	O
samples	O
.	O

miR	O
-	O
506	O
was	O
detected	O
in	O
501mel	O
and	O
MeWo	O
cells	O
.	O

The	O
expression	O
level	O
was	O
higher	O
in	O
MeWo	O
cells	O
(	O
Cp	O
value	O
32	O
.	O
9	O
)	O
compared	O
to	O
501mel	O
cells	O
(	O
Cp	O
value	O
34	O
.	O
7	O
).	O

Lower	O
expression	O
in	O
501mel	O
might	O
be	O
a	O
factor	O
allowing	O
a	O
high	O
level	O
of	O
MITF	B-GP
expression	O
in	O
this	O
melanoma	B-DS
cell	O
type	O
.	O

Discussion	O

We	O
have	O
tested	O
the	O
role	O
of	O
six	O
different	O
miRNAs	O
with	O
conserved	O
potential	O
binding	O
sites	O
in	O
the	O
Mitf	B-GP
3	O
′	O
UTR	O
sequence	O
for	O
their	O
ability	O
to	O
affect	O
Mitf	B-GP
mRNA	O
expression	O
.	O

We	O
show	O
that	O
miR	O
-	O
137	O
and	O
miR	O
-	O
148	O
negatively	O
affect	O
Mitf	B-GP
mRNA	O
in	O
melanoma	B-DS
cells	O
through	O
conserved	O
binding	O
sites	O
in	O
the	O
3	O
′	O
UTR	O
sequence	O
.	O

Other	O
miRNAs	O
tested	O
,	O
miR	O
-	O
27	O
and	O
miR	O
-	O
25	O
/	O
32	O
/	O
92	O
/	O
363	O
/	O
367	O
have	O
highly	O
conserved	O
binding	O
sites	O
but	O
did	O
not	O
have	O
an	O
effect	O
on	O
reporter	O
gene	O
expression	O
in	O
HEK293	O
or	O
501mel	O
cells	O
.	O

The	O
microRNA	O
miR	O
-	O
101	O
has	O
a	O
highly	O
conserved	O
binding	O
site	O
but	O
did	O
not	O
affect	O
reporter	O
gene	O
expression	O
in	O
HEK293	O
cells	O
.	O

However	O
in	O
501mel	O
cells	O
,	O
miR	O
-	O
101	O
downregulated	O
reporter	O
gene	O
expression	O
at	O
the	O
two	O
highest	O
concentrations	O
used	O
suggesting	O
that	O
it	O
may	O
play	O
a	O
role	O
in	O
melanocytes	O
or	O
melanoma	B-DS
cells	O
.	O

The	O
roles	O
of	O
miR	O
-	O
137	O
and	O
miR	O
-	O
148	O
were	O
analysed	O
further	O
by	O
mutating	O
the	O
binding	O
sites	O
in	O
the	O
mouseMitf	B-GP
-	O
3	O
′	O
UTR	O
-	O
luciferase	B-GP
reporter	O
construct	O
.	O

The	O
results	O
of	O
this	O
analysis	O
suggest	O
direct	O
effects	O
on	O
the	O
Mitf	B-GP
mRNA	O
.	O

When	O
the	O
148	O
/	O
152B	O
binding	O
sites	O
were	O
mutated	O
,	O
the	O
effects	O
of	O
miR	O
-	O
148	O
were	O
eliminated	O
.	O

When	O
the	O
most	O
conserved	O
binding	O
sites	O
for	O
miR	O
-	O
137	O
(	O
137C	O
and	O
D	O
)	O
were	O
mutated	O
,	O
the	O
effects	O
of	O
miR	O
-	O
137	O
were	O
eliminated	O
.	O

None	O
of	O
the	O
miR	O
-	O
137	O
-	O
mutations	O
restore	O
luciferase	B-GP
expression	O
to	O
the	O
level	O
observed	O
with	O
the	O
negative	O
control	O
.	O

This	O
might	O
indicate	O
that	O
all	O
the	O
miR	O
-	O
137	O
binding	O
sites	O
contribute	O
to	O
the	O
regulation	O
of	O
Mitf	B-GP
.	O

However	O
,	O
it	O
should	O
be	O
noted	O
that	O
miR	O
-	O
137	O
can	O
target	O
the	O
luciferase	B-GP
construct	O
lacking	O
the	O
3	O
′	O
UTR	O
sequence	O
such	O
that	O
in	O
the	O
presence	O
of	O
miR	O
-	O
137	O
,	O
luciferase	B-GP
expression	O
cannot	O
reach	O
the	O
same	O
level	O
of	O
expression	O
as	O
is	O
seen	O
with	O
the	O
negative	O
control	O
(	O
miR	O
-	O
neg	O
#	O
2	O
).	O

The	O
effects	O
of	O
the	O
miRNAs	O
were	O
further	O
confirmed	O
by	O
transfecting	O
the	O
microRNAs	O
into	O
MeWo	O
melanoma	B-DS
cells	O
and	O
then	O
measuring	O
the	O
endogenous	O
MITF	B-GP
mRNA	O
and	O
protein	O
levels	O
.	O

miR	O
-	O
137	O
and	O
miR	O
-	O
148	O
both	O
led	O
to	O
reduced	O
levels	O
of	O
MITF	B-GP
mRNA	O
and	O
protein	O
.	O

Simultaneous	O
transfection	O
with	O
anti	O
-	O
miR	O
-	O
148	O
blocked	O
the	O
effect	O
of	O
miR	O
-	O
148	O
in	O
both	O
the	O
luciferase	B-GP
reporter	O
assays	O
and	O
on	O
the	O
endogenous	O
MITF	B-GP
mRNA	O
.	O

Transfection	O
with	O
anti	O
-	O
miR	O
-	O
137	O
similarly	O
blocked	O
the	O
effects	O
of	O
miR	O
-	O
137	O
on	O
the	O
endogenous	O
MITF	B-GP
mRNA	O
(	O
Fig	O
.	O
5B	O
).	O

miR	O
-	O
137	O
did	O
not	O
significantly	O
affect	O
the	O
luciferase	B-GP
reporter	O
in	O
melanoma	B-DS
cells	O
.	O

However	O
,	O
simultaneous	O
transfection	O
of	O
anti	O
-	O
miR	O
-	O
137	O
and	O
miR	O
-	O
137	O
with	O
the	O
Mitf	B-GP
-	O
3	O
′	O
UTR	O
luciferase	B-GP
in	O
MeWo	O
cells	O
blocked	O
the	O
effect	O
of	O
miR	O
-	O
137	O
(	O
data	O
not	O
shown	O
).	O

Combining	O
both	O
miR	O
-	O
137	O
and	O
miR	O
-	O
148	O
did	O
not	O
result	O
in	O
added	O
effects	O
on	O
endogenous	O
MITF	B-GP
mRNA	O
levels	O
.	O

Possible	O
explanations	O
for	O
this	O
might	O
be	O
that	O
the	O
maximum	O
effects	O
are	O
reached	O
with	O
one	O
of	O
the	O
miRNAs	O
and	O
adding	O
another	O
does	O
not	O
increase	O
the	O
effects	O
.	O

Another	O
explanation	O
for	O
the	O
lack	O
of	O
additive	O
effects	O
is	O
that	O
the	O
miRNAs	O
might	O
not	O
be	O
able	O
to	O
bind	O
simultaneously	O
to	O
the	O
3	O
′	O
UTR	O
sequences	O
.	O

The	O
137C	O
,	O
137D	O
and	O
148	O
/	O
152B	O
binding	O
sites	O
are	O
all	O
located	O
in	O
close	O
proximity	O
to	O
each	O
other	O
in	O
the	O
Mitf	B-GP
-	O
3	O
′	O
UTR	O
sequence	O
(	O
Fig	O
.	O
1A	O
).	O

Accessibility	O
might	O
be	O
limited	O
by	O
one	O
of	O
the	O
miRNAs	O
.	O

A	O
third	O
possibility	O
is	O
that	O
specific	O
binding	O
proteins	O
block	O
the	O
other	O
sites	O
when	O
one	O
is	O
occupied	O
.	O

Specific	O
RNA	B-GP
binding	I-GP
proteins	I-GP
have	O
been	O
show	O
to	O
block	O
the	O
binding	O
of	O
miRNAs	O
to	O
the	O
MITF	B-GP
mRNA	O
[	O
44	O
].	O

The	O
fact	O
that	O
miR	O
-	O
137	O
has	O
an	O
effect	O
in	O
MeWo	O
cells	O
(	O
q	O
-	O
RT	O
-	O
PCR	O
)	O
and	O
not	O
in	O
501mel	O
cells	O
might	O
be	O
due	O
to	O
the	O
fact	O
that	O
MITF	B-GP
mRNA	O
levels	O
are	O
higher	O
in	O
501mel	O
cells	O
than	O
in	O
MeWo	O
cells	O
.	O

Thus	O
,	O
more	O
miR	O
-	O
137	O
might	O
be	O
needed	O
in	O
501mel	O
cells	O
then	O
in	O
MeWo	O
cells	O
.	O

The	O
effects	O
of	O
miR	O
-	O
137	O
and	O
miR	O
-	O
148	O
when	O
transfected	O
seperatly	O
,	O
are	O
blocked	O
when	O
the	O
cells	O
are	O
transfected	O
with	O
miR	O
-	O
137	O
and	O
miR	O
-	O
148	O
inhibitors	O
.	O

miR	O
-	O
124	O
resulted	O
in	O
increased	O
luciferase	B-GP
expression	O
as	O
seen	O
using	O
the	O
reporter	O
gene	O
construct	O
in	O
HEK293	O
cells	O
.	O

Furthermore	O
,	O
we	O
observed	O
upregulation	O
of	O
the	O
endogenous	O
MITF	B-GP
in	O
MeWo	O
cells	O
at	O
both	O
mRNA	O
and	O
protein	O
levels	O
;	O
the	O
upregulation	O
of	O
MITF	B-GP
mRNA	O
was	O
not	O
statistically	O
significant	O
.	O

The	O
effects	O
of	O
miR	O
-	O
124	O
might	O
be	O
an	O
artifact	O
of	O
the	O
reporter	O
system	O
.	O

The	O
effects	O
on	O
endogenous	O
MITF	B-GP
could	O
not	O
be	O
measured	O
in	O
HEK293	O
cells	O
as	O
there	O
is	O
no	O
endogenous	O
MITF	B-GP
expression	O
in	O
those	O
cells	O
.	O

As	O
mentioned	O
earlier	O
,	O
miR	O
-	O
137	O
has	O
previously	O
been	O
shown	O
to	O
target	O
MITF	B-GP
in	O
melanoma	B-DS
cells	O
[	O
31	O
].	O

Interestingly	O
,	O
searching	O
for	O
miR	O
-	O
137	O
binding	O
sites	O
within	O
the	O
Mitf	B-GP
3	O
′	O
UTR	O
sequence	O
of	O
11	O
vertebrate	O
species	O
revealed	O
that	O
all	O
species	O
have	O
at	O
least	O
two	O
miR	O
-	O
137	O
binding	O
sites	O
and	O
some	O
species	O
have	O
three	O
or	O
four	O
binding	O
sites	O
.	O

All	O
species	O
contain	O
either	O
137C	O
or	O
137D	O
and	O
nine	O
contain	O
them	O
both	O
(	O
data	O
not	O
shown	O
).	O

miR	O
-	O
137	O
expression	O
has	O
been	O
shown	O
to	O
be	O
affected	O
in	O
cancer	B-DS
.	O

It	O
is	O
silenced	O
by	O
DNA	O
methylation	O
in	O
colorectal	B-DS
cancer	I-DS
[	O
45	O
]	O
and	O
oral	O
carcinogenesis	O
[	O
46	O
],	O
suggesting	O
tumor	B-DS
suppressor	O
abilities	O
.	O

In	O
addition	O
,	O
both	O
miR	O
-	O
137	O
and	O
miR	O
-	O
124	O
induced	O
differentiation	O
of	O
adult	O
mouse	B-OG
neural	O
stem	O
cells	O
and	O
were	O
able	O
to	O
induce	O
cell	O
cycle	O
arrest	O
of	O
glioblastoma	B-DS
multiforme	I-DS
cells	O
[	O
47	O
].	O

Upregulation	O
of	O
miR	O
-	O
137	O
in	O
lymph	O
node	O
metastasis	O
in	O
colon	B-DS
cancer	I-DS
has	O
also	O
been	O
observed	O
[	O
48	O
].	O

The	O
3	O
′	O
UTR	O
sequences	O
of	O
Mitf	B-GP
in	O
11	O
vertebrate	O
species	O
all	O
contain	O
the	O
two	O
conserved	O
miR	O
-	O
148	O
/	O
152	O
binding	O
sites	O
.	O

In	O
six	O
vertebrate	O
species	O
there	O
is	O
an	O
additional	O
conserved	O
binding	O
site	O
(	O
data	O
not	O
shown	O
).	O

It	O
has	O
not	O
been	O
shown	O
previously	O
that	O
miR	O
-	O
148	O
and	O
/	O
or	O
miR	O
-	O
152	O
can	O
target	O
Mitf	B-GP
.	O
However	O
,	O
both	O
miRNAs	O
have	O
been	O
shown	O
to	O
be	O
downregulated	O
in	O
melanoma	B-DS
cells	O
[	O
30	O
].	O

Microarray	O
analysis	O
revealed	O
that	O
miR	O
-	O
148b	O
is	O
downregulated	O
in	O
early	O
melanoma	B-DS
progression	O
,	O
although	O
it	O
was	O
not	O
confirmed	O
using	O
qRT	O
-	O
PCR	O
[	O
30	O
].	O

Similarly	O
,	O
miR	O
-	O
152	O
was	O
shown	O
to	O
be	O
downregulated	O
in	O
a	O
highly	O
invasive	B-DS
melanoma	I-DS
cell	O
line	O
(	O
Mel	O
Im	O
)	O
[	O
30	O
].	O

Other	O
studies	O
have	O
suggested	O
that	O
miR	O
-	O
148	O
and	O
miR	O
-	O
152	O
can	O
play	O
a	O
role	O
as	O
tumor	B-DS
suppressors	O
.	O

miR	O
-	O
148	O
expression	O
has	O
been	O
shown	O
to	O
be	O
downregulated	O
in	O
tissue	O
samples	O
from	O
undifferentiated	O
gastric	B-DS
cancer	I-DS
compared	O
to	O
normal	O
tissue	O
[	O
49	O
].	O

Similarly	O
,	O
hypermethylation	O
of	O
the	O
miR	O
-	O
148	O
,	O
124a3	O
and	O
miR	O
-	O
152	O
genes	O
was	O
found	O
in	O
34	O
-	O
86	O
%	O
of	O
primary	O
human	B-OG
breast	B-DS
cancer	I-DS
specimens	O
[	O
50	O
].	O

The	O
binding	O
sites	O
for	O
microRNAs	O
miR	O
-	O
124	O
/	O
506	O
are	O
very	O
well	O
conserved	O
in	O
the	O
Mitf	B-GP
3	O
′	O
UTR	O
sequence	O
.	O

Ten	O
vertebrate	O
species	O
contain	O
both	O
miR	O
-	O
124	O
/	O
506	O
binding	O
site	O
;	O
the	O
Loxodonta	B-OG
africana	I-OG
sequence	O
only	O
contains	O
124	O
/	O
506B	O
.	O

It	O
has	O
not	O
been	O
shown	O
previously	O
that	O
miR	O
-	O
124	O
and	O
/	O
or	O
miR	O
-	O
506	O
can	O
affect	O
Mitf	B-GP
mRNA	O
.	O

However	O
,	O
miR	O
-	O
506	O
was	O
shown	O
to	O
be	O
upregulated	O
in	O
early	O
melanoma	B-DS
progression	O
and	O
downregulated	O
later	O
in	O
metastatic	B-DS
melanoma	I-DS
[	O
30	O
]	O
and	O
may	O
therefore	O
play	O
an	O
important	O
role	O
in	O
this	O
cell	O
type	O
.	O

miR	O
-	O
124	O
is	O
predominantly	O
expressed	O
in	O
the	O
brain	O
,	O
specifically	O
in	O
differentiating	O
and	O
mature	O
neurons	O
[	O
51	O
],	O
[	O
52	O
],	O
[	O
53	O
].	O

miR	O
-	O
124	O
is	O
interesting	O
considering	O
its	O
expression	O
in	O
the	O
retina	O
[	O
54	O
],	O
as	O
Mitf	B-GP
plays	O
an	O
important	O
role	O
in	O
eye	O
development	O
.	O
Mitf	B-GP
is	O
expressed	O
in	O
the	O
retina	O
early	O
in	O
development	O
and	O
is	O
later	O
downregulated	O
in	O
this	O
tissue	O
[	O
55	O
],	O
[	O
56	O
],	O
[	O
57	O
].	O

The	O
mechanisms	O
that	O
mediate	O
this	O
downregulation	O
have	O
not	O
been	O
described	O
and	O
may	O
involve	O
miR	O
-	O
124	O
.	O

However	O
,	O
our	O
results	O
show	O
upregulation	O
by	O
miR	O
-	O
124	O
in	O
melanoma	B-DS
cells	O
,	O
rather	O
than	O
downregulation	O
.	O

The	O
possible	O
role	O
of	O
miR	O
-	O
124	O
in	O
regulating	O
the	O
expression	O
of	O
Mitf	B-GP
during	O
eye	O
development	O
needs	O
to	O
be	O
tested	O
further	O
.	O

Although	O
miRNAs	O
are	O
better	O
known	O
for	O
downregulating	O
target	O
genes	O
,	O
there	O
have	O
been	O
reports	O
on	O
effects	O
through	O
upregulation	O
by	O
miRNAs	O
by	O
binding	O
to	O
their	O
promoter	O
region	O
[	O
58	O
],	O
[	O
59	O
].	O

However	O
,	O
this	O
is	O
unlikely	O
to	O
play	O
a	O
role	O
in	O
regulating	O
Mitf	B-GP
mRNA	O
through	O
effects	O
on	O
the	O
3	O
′	O
UTR	O
since	O
our	O
reporter	O
construct	O
only	O
contained	O
3	O
′	O
UTR	O
sequences	O
.	O

It	O
has	O
been	O
shown	O
that	O
two	O
thirds	O
of	O
genes	O
targeted	O
by	O
miRNA	O
have	O
alternative	O
3	O
′	O
UTRs	O
.	O

The	O
microRNAs	O
miR	O
-	O
137	O
and	O
miR	O
-	O
148	O
have	O
many	O
other	O
potential	O
target	O
genes	O
according	O
to	O
online	O
prediction	O
programs	O
(	O
Targetscan	O
).	O

In	O
humans	B-OG
,	O
miR	O
-	O
137	O
has	O
857	O
conserved	O
targets	O
,	O
with	O
a	O
total	O
of	O
949	O
conserved	O
sites	O
and	O
120	O
poorly	O
conserved	O
sites	O
.	O

miR	O
-	O
148	O
has	O
536	O
conserved	O
targets	O
,	O
with	O
a	O
total	O
of	O
581	O
conserved	O
sites	O
and	O
134	O
poorly	O
conserved	O
sites	O
.	O

Of	O
these	O
potential	O
target	O
genes	O
,	O
66	O
are	O
common	O
targets	O
of	O
both	O
miR	O
-	O
137	O
and	O
miR	O
-	O
148	O
.	O

It	O
is	O
therefore	O
unlikely	O
that	O
these	O
miRNAs	O
exclusively	O
affect	O
Mitf	B-GP
expression	O
.	O

As	O
miRNA	O
binding	O
sites	O
are	O
often	O
located	O
close	O
to	O
polyadenylation	O
signals	O
(	O
PAS	O
)	O
[	O
60	O
],	O
shortening	O
of	O
the	O
3	O
′	O
UTRs	O
may	O
lead	O
to	O
loss	O
of	O
miRNA	O
binding	O
sequences	O
and	O
thus	O
loss	O
of	O
microRNA	O
-	O
mediated	O
regulation	O
.	O

The	O
mouse	B-OG
Mitf	B-GP
3	O
′	O
UTR	O
sequence	O
contains	O
twelve	O
potential	O
PAS	O
sequences	O
(	O
two	O
are	O
AAUAAA	O
,	O
four	O
AUUAAA	O
,	O
four	O
AAGAAA	O
and	O
two	O
UAUAAA	O
,	O
there	O
is	O
no	O
AGUAAA	O
sequence	O
).	O

Comparing	O
these	O
potential	O
PAS	O
sites	O
in	O
the	O
3	O
′	O
UTR	O
sequences	O
of	O
Mitf	B-GP
from	O
11	O
vertebrate	O
species	O
revealed	O
a	O
well	O
conserved	O
PAS	O
located	O
at	O
2837	O
-	O
2842	O
,	O
adjacent	O
to	O
the	O
miR	O
-	O
137	O
C	O
binding	O
site	O
(	O
Fig	O
.	O
1A	O
).	O

Ten	O
species	O
contain	O
a	O
PAS	O
at	O
this	O
location	O
.	O

The	O
PAS	O
located	O
closest	O
to	O
the	O
3	O
′	O
end	O
is	O
conserved	O
in	O
all	O
species	O
and	O
represents	O
the	O
signal	O
for	O
the	O
longest	O
mRNA	O
version	O
.	O

Several	O
other	O
PAS	O
'	O
s	O
are	O
well	O
conserved	O
whereas	O
others	O
are	O
less	O
conserved	O
.	O

miRNAs	O
can	O
have	O
an	O
impact	O
on	O
cancer	B-DS
progression	O
in	O
several	O
ways	O
,	O
including	O
loss	O
of	O
expression	O
of	O
a	O
tumor	B-DS
-	O
suppressor	O
miRNA	O
gene	O
and	O
over	O
-	O
activation	O
of	O
an	O
oncogenic	O
miRNA	O
.	O

Loss	O
of	O
miRNA	O
binding	O
sites	O
in	O
3	O
′	O
UTR	O
sequences	O
of	O
the	O
target	O
genes	O
caused	O
by	O
mutations	O
or	O
translocations	O
are	O
also	O
possible	O
.	O

Shortening	O
of	O
the	O
3	O
′	O
UTR	O
sequence	O
,	O
and	O
therefore	O
loss	O
of	O
miRNA	O
binding	O
sites	O
,	O
can	O
lead	O
to	O
oncogenic	O
activation	O
[	O
61	O
].	O

The	O
conservation	O
of	O
several	O
of	O
the	O
alternative	O
polyadenylation	O
signals	O
found	O
in	O
the	O
3	O
′	O
UTR	O
sequences	O
of	O
Mitf	B-GP
suggests	O
their	O
significance	O
.	O

Thus	O
,	O
Mitf	B-GP
might	O
be	O
able	O
to	O
evade	O
miRNA	O
-	O
mediated	O
regulation	O
using	O
the	O
alternative	O
polyadenylation	O
sites	O
,	O
thus	O
leading	O
to	O
a	O
shorter	O
transcript	O
lacking	O
the	O
miRNA	O
binding	O
sequences	O
.	O

It	O
was	O
recently	O
shown	O
that	O
MITF	B-GP
mRNAs	O
with	O
shorter	O
3	O
′	O
UTR	O
sequences	O
are	O
more	O
abundant	O
in	O
melanoma	B-DS
cell	O
lines	O
than	O
transcripts	O
with	O
full	O
-	O
length	O
3	O
′	O
UTR	O
sequences	O
[	O
44	O
].	O

In	O
this	O
case	O
the	O
miR	O
-	O
340	O
is	O
involved	O
in	O
regulating	O
the	O
shorter	O
transcript	O
and	O
,	O
interestingly	O
,	O
the	O
RNA	B-GP
binding	I-GP
protein	I-GP
CRD	B-GP
-	I-GP
BP	I-GP
prevents	O
binding	O
of	O
the	O
miRNA	O
.	O

Thus	O
,	O
in	O
the	O
case	O
of	O
MITF	B-GP
,	O
microRNAs	O
do	O
not	O
act	O
alone	O
in	O
mediating	O
regulation	O
through	O
the	O
3	O
′	O
UTR	O
sequences	O
.	O

Interestingly	O
,	O
the	O
MITF	B-GP
protein	O
has	O
been	O
shown	O
to	O
bind	O
to	O
the	O
promoter	O
of	O
miR	O
-	O
148b	O
that	O
is	O
shown	O
there	O
to	O
have	O
functional	O
target	O
site	O
within	O
the	O
Mitf	B-GP
3	O
′	O
UTR	O
sequence	O
[	O
62	O
].	O

This	O
indicates	O
a	O
possible	O
negative	O
feedback	O
loop	O
where	O
higher	O
amounts	O
of	O
MITF	B-GP
would	O
lead	O
to	O
more	O
miR	O
-	O
148	O
expression	O
which	O
in	O
turn	O
adjusts	O
MITF	B-GP
protein	O
at	O
desirable	O
levels	O
.	O

It	O
is	O
clear	O
that	O
miRNA	O
function	O
is	O
diverse	O
and	O
its	O
role	O
in	O
cancer	B-DS
and	O
other	O
disease	O
is	O
complex	O
.	O

Some	O
miRNAs	O
seem	O
to	O
have	O
a	O
tissue	O
-	O
specific	O
function	O
like	O
miR	O
-	O
124	O
in	O
neurons	O
wheras	O
other	O
miRNAs	O
are	O
found	O
more	O
universally	O
.	O
Mitf	B-GP
functions	O
in	O
diverse	O
cell	O
types	O
and	O
may	O
therefore	O
be	O
regulated	O
by	O
different	O
miRNAs	O
in	O
the	O
different	O
tissues	O
.	O

In	O
melanoma	B-DS
cells	O
,	O
Mitf	B-GP
is	O
regulated	O
by	O
miR	O
-	O
137	O
and	O
miR	O
-	O
148	O
/	O
152	O
.	O

As	O
MITF	B-GP
is	O
a	O
lineage	O
survival	O
oncogene	B-GP
in	O
melanoma	B-DS
[	O
23	O
]	O
whose	O
expression	O
needs	O
to	O
be	O
maintained	O
at	O
a	O
certain	O
level	O
,	O
it	O
is	O
likely	O
that	O
these	O
miRNAs	O
play	O
an	O
important	O
role	O
in	O
regulating	O
MITF	B-GP
mRNA	O
levels	O
in	O
this	O
cell	O
type	O
.	O

Dysregulation	O
of	O
these	O
microRNAs	O
,	O
or	O
loss	O
of	O
the	O
binding	O
sites	O
in	O
the	O
3	O
′	O
UTR	O
,	O
might	O
lead	O
to	O
increased	O
expression	O
of	O
Mitf	B-GP
,	O
thus	O
leading	O
to	O
differentiation	O
and	O
cell	O
-	O
cycle	O
arrest	O
.	O

As	O
the	O
miRNAs	O
involved	O
may	O
have	O
significant	O
therapeutic	O
potential	O
,	O
it	O
will	O
be	O
important	O
to	O
characterize	O
this	O
regulation	O
in	O
more	O
detail	O
in	O
further	O
studies	O
.	O

Supporting	O
Information	O

P	O
-	O
values	O
for	O
data	O
presented	O
in	O
Figures	O
2	O
and	O
3	O
.	O

(	O
0	O
.	O
02	O
MB	O
PDF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Competing	O
Interests	O
:	O
The	O
authors	O
have	O
declared	O
that	O
no	O
competing	O
interests	O
exist	O
.	O

